Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Robert Califf

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Devices

Electrocardiography

Phenomena

Recurrence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
311
Topol, Eric
131
Harrington, Robert
107
Granger, Christopher
96
White, Harvey
82
Ohman, Magnus
75
Van de Werf, Frans
67
Armstrong, Paul
66
Simoons, Maarten
61
Lincoff, Michael
60
Lee, Kerry
56
Kereiakes, Dean
53
Mahaffey, Kenneth
48
O'Connor, Christopher
47
Newby, Kristin
42
Peterson, Eric

Sign-in to see all Coauthors

Publications

TOP 3
Califf Robert M
Clinical research sites--the underappreciated component of the clinical research system.
Linefsky Jason P; Lin Min; Pieper Karen S; Reist Craig J; Berdan Lisa G; Antman Elliott M; Goodman Shaun G; French John K; Guneri Sema; Roe Matthew T; Newby L Kristin; Harrington Robert A; Ferguson James J; Califf Robert M; Mahaffey Kenneth W
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
Al-Khatib Sana M; Hafley Gail; Harrington Robert A; Mack Michael J; Ferguson Thomas Bruce; Peterson Eric D; Califf Robert M; Kouchoukos Nicholas T; Alexander John H
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Robert Califf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Califf Robert M
Clinical research sites--the underappreciated component of the clinical research system.
JAMA : the journal of the American Medical Association 2009;302(18):2025-7.
2009: Linefsky Jason P; Lin Min; Pieper Karen S; Reist Craig J; Berdan Lisa G; Antman Elliott M; Goodman Shaun G; French John K; Guneri Sema; Roe Matthew T; Newby L Kristin; Harrington Robert A; Ferguson James J; Califf Robert M; Mahaffey Kenneth W
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
The American journal of cardiology 2009;104(10):1330-5.
2009: Al-Khatib Sana M; Hafley Gail; Harrington Robert A; Mack Michael J; Ferguson Thomas Bruce; Peterson Eric D; Califf Robert M; Kouchoukos Nicholas T; Alexander John H
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial.
American heart journal 2009;158(5):792-8.
2009: Piccini Jonathan P; Hasselblad Vic; Peterson Eric D; Washam Jeffrey B; Califf Robert M; Kong David F
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
Journal of the American College of Cardiology 2009;54(12):1089-95.
2009: Bonaca Marc P; Steg Philippe Gabriel; Feldman Laurent J; Canales John F; Ferguson James J; Wallentin Lars; Califf Robert M; Harrington Robert A; Giugliano Robert P
Antithrombotics in acute coronary syndromes.
Journal of the American College of Cardiology 2009;54(11):969-84.
2009: Kumar Amit; Fonarow Gregg C; Eagle Kim A; Hirsch Alan T; Califf Robert M; Alberts Mark J; Boden William E; Steg P Gabriel; Shao Mingyuan; Bhatt Deepak L; Cannon Christopher P;
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Critical pathways in cardiology 2009;8(3):104-11.
2009: Moukarbel George V; Signorovitch James E; Pfeffer Marc A; McMurray John J V; White Harvey D; Maggioni Aldo P; Velazquez Eric J; Califf Robert M; Scheiman James M; Solomon Scott D
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
European heart journal 2009;30(18):2226-32.
2009: Berger Jeffrey S; Elliott Laine; Gallup Dianne; Roe Matthew; Granger Christopher B; Armstrong Paul W; Simes R John; White Harvey D; Van de Werf Frans; Topol Eric J; Hochman Judith S; Newby L Kristin; Harrington Robert A; Califf Robert M; Becker Richard C; Douglas Pamela S
Sex differences in mortality following acute coronary syndromes.
JAMA : the journal of the American Medical Association 2009;302(8):874-82.
2009: Califf Robert M;
Key issues for global cardiovascular medicine.
Lancet 2009;374(9689):508-10.
2009: Califf Robert M; Harrington Robert A; Blazing Michael A
Premature release of data from clinical trials of ezetimibe.
The New England journal of medicine 2009;361(7):712-7.
2009: Lopes Renato D; Hafley Gail E; Allen Keith B; Ferguson T Bruce; Peterson Eric D; Harrington Robert A; Mehta Rajendra H; Gibson C Michael; Mack Michael J; Kouchoukos Nicholas T; Califf Robert M; Alexander John H
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery.
The New England journal of medicine 2009;361(3):235-44.
2009: Califf Robert M
Rational use of medications: if Canada can't do it ...
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2009;181(1-2):15-6.
2009: Califf Robert M; Lokhnygina Yuliya; Velazquez Eric J; McMurray John J V; Leimberger Jeffrey D; Lewis Eldrin F; Diaz Rafael; Murin Jan; Pfeffer Marc A
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
The American journal of cardiology 2009;104(2):151-7.
2009: Harrington Robert A; Califf Robert M; Hodgson Patricia K; Peterson Eric D; Roe Matthew T; Mark Daniel B
Careers for clinician investigators.
Circulation 2009;119(22):2945-50.
2009: Chan Mark Y; Sun Jie L; Newby L Kristin; Shaw Linda K; Lin Min; Peterson Eric D; Califf Robert M; Kong David F; Roe Matthew T
Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction.
Circulation 2009;119(24):3110-7.
2009: Turer Aslan T; Mahaffey Kenneth W; Honeycutt Emily; Tuttle Robert H; Shaw Linda K; Sketch Michael H; Smith Peter K; Califf Robert M; Alexander John H
Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease.
The Journal of thoracic and cardiovascular surgery 2009;137(6):1468-74.
2009: Eagle Kim A; Hirsch Alan T; Califf Robert M; Alberts Mark J; Steg P Gabriel; Cannon Christopher P; Brennan Danielle M; Bhatt Deepak L;
Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
Critical pathways in cardiology 2009;8(2):91-7.
2009: Berry Colin; Pieper Karen S; White Harvey D; Solomon Scott D; Van de Werf Frans; Velazquez Eric J; Maggioni Aldo P; Califf Robert M; Pfeffer Marc A; McMurray John J V
Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).
European heart journal 2009;30(12):1450-6.
2009: Giugliano Robert P; White Jennifer A; Bode Christoph; Armstrong Paul W; Montalescot Gilles; Lewis Basil S; van 't Hof Arnoud; Berdan Lisa G; Lee Kerry L; Strony John T; Hildemann Steven; Veltri Enrico; Van de Werf Frans; Braunwald Eugene; Harrington Robert A; Califf Robert M; Newby L Kristin;
Early versus delayed, provisional eptifibatide in acute coronary syndromes.
The New England journal of medicine 2009;360(21):2176-90.
2009: Califf Robert M; Peterson Eric D
Public reporting of quality measures what are we trying to accomplish?
Journal of the American College of Cardiology 2009;53(10):831-3.
2009: Tricoci Pierluigi; Allen Joseph M; Kramer Judith M; Califf Robert M; Smith Sidney C
Scientific evidence underlying the ACC/AHA clinical practice guidelines.
JAMA : the journal of the American Medical Association 2009;301(8):831-41.
2009: Glickman Seth W; McHutchison John G; Peterson Eric D; Cairns Charles B; Harrington Robert A; Califf Robert M; Schulman Kevin A
Ethical and scientific implications of the globalization of clinical research.
The New England journal of medicine 2009;360(8):816-23.
2009: Hernandez Adrian F; O'Connor Christopher M; Starling Randall C; Reist Craig J; Armstrong Paul W; Dickstein Kenneth; Lorenz Todd J; Gibler W Brian; Hasselblad Vic; Komajda Michel; Massie Barry; McMurray John J V; Nieminen Markku; Rouleau Jean L; Swedberg Karl; Califf Robert M
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
American heart journal 2009;157(2):271-7.
2009: Ezekowitz Justin A; Hernandez Adrian F; Starling Randall C; Yancy Clyde W; Massie Barry; Hill James A; Krum Henry; Diaz Rafael; Ponikowski Piotr; Metra Marco; Howlett Jonathon G; Gennevois Daniel; O'Connor Christopher M; Califf Robert M; Fonarow Gregg C
Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
American heart journal 2009;157(2):219-28.
2009: Califf Robert M
A virtuous cycle to improve hypertension outcomes at a national level: linking public health and individualized medicine.
Hypertension 2009;53(2):105-7.
2009: Mehta Rajendra H; Rogers Joseph G; Hasselblad Vic; Tasissa Gudaye; Binanay Cynthia; Califf Robert M; O'Connor Christopher M;
Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure.
The American journal of cardiology 2009;103(1):76-81.
2008: Califf Robert M
The benefits of moving quality to a national level.
American heart journal 2008;156(6):1019-22.
2008: Piccini Jonathan P; Hranitzky Patrick M; Kilaru Rakhi; Rouleau Jean-Lucien; White Harvey D; Aylward Philip E; Van de Werf Frans; Solomon Scott D; Califf Robert M; Velazquez Eric J
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
The American journal of cardiology 2008;102(11):1427-32.
2008: Califf Robert M; Rasiel Emma B; Schulman Kevin A
Considerations of net present value in policy making regarding diagnostic and therapeutic technologies.
American heart journal 2008;156(5):879-85.
2008: Cannon Christopher P; Giugliano Robert P; Blazing Michael A; Harrington Robert A; Peterson John L; Sisk Christine McCrary; Strony John; Musliner Thomas A; McCabe Carolyn H; Veltri Enrico; Braunwald Eugene; Califf Robert M;
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
American heart journal 2008;156(5):826-32.
2008: Mehta Rajendra H; Hafley Gail E; Gibson C Michael; Harrington Robert A; Peterson Eric D; Mack Michael J; Kouchoukos Nicholas T; Califf Robert M; Ferguson T Bruce; Alexander John H;
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.
The Journal of thoracic and cardiovascular surgery 2008;136(5):1149-55.
2008: Califf Robert M; Ginsburg Geoffrey S
Organizational improvements to enhance modern clinical epidemiology.
JAMA : the journal of the American Medical Association 2008;300(19):2300-2.
2008: Stevenson Lynne W; Hellkamp Anne S; Leier Carl V; Sopko George; Koelling Todd; Warnica J Wayne; Abraham William T; Kasper Edward K; Rogers Joseph G; Califf Robert M; Schramm Elizabeth E; O'Connor Christopher M
Changing preferences for survival after hospitalization with advanced heart failure.
Journal of the American College of Cardiology 2008;52(21):1702-8.
2008: O'Connor Christopher M; Jiang Wei; Kuchibhatla Maragatha; Mehta Rajendra H; Clary Greg L; Cuffe Michael S; Christopher Eric J; Alexander Jude D; Califf Robert M; Krishnan Ranga R
Antidepressant use, depression, and survival in patients with heart failure.
Archives of internal medicine 2008;168(20):2232-7.
2008: Aronow Herbert D; Califf Robert M; Harrington Robert A; Vallee Marc; Graffagnino Carmelo; Shuaib Ashfaq; Fitzgerald Desmond J; Easton J Donald; Van de Werf Frans; Diener Hans-Christoph; Ferguson James; Koudstaal Peter J; Amarenco Pierre; Theroux Pierre; Davis Stephen; Topol Eric J
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).
The American journal of cardiology 2008;102(10):1285-90.
2008: Novak James E; Inrig Jula K; Patel Uptal D; Califf Robert M; Szczech Lynda A
Negative trials in nephrology: what can we learn?
Kidney international 2008;74(9):1121-7.
2008: Califf Robert M; Boolell Mitradev; Haffner Steven M; Bethel M Angelyn; McMurray John; Duggal Anil; Holman Rury R;
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
American heart journal 2008;156(4):623-32.
2008: Allen Larry A; Rogers Joseph G; Warnica J Wayne; Disalvo Thomas G; Tasissa Gudaye; Binanay Cynthia; O'Connor Christopher M; Califf Robert M; Leier Carl V; Shah Monica R; Stevenson Lynne W;
High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization.
Journal of cardiac failure 2008;14(8):661-9.
2008: Baker-Smith Carissa M; Benjamin Daniel K; Grabowski Henry G; Reid Elizabeth D; Mangum Barry; Goldsmith John V; Murphy M Dianne; Edwards Rex; Eisenstein Eric L; Sun Jessica; Califf Robert M; Li Jennifer S
The economic returns of pediatric clinical trials of antihypertensive drugs.
American heart journal 2008;156(4):682-8.
2008: Bethel M Angelyn; Holman Rury; Haffner Steven M; Califf Robert M; Huntsman-Labed Alice; Hua Tsushung A; McMurray John
Determining the most appropriate components for a composite clinical trial outcome.
American heart journal 2008;156(4):633-40.
2008: Drazner Mark H; Hellkamp Anne S; Leier Carl V; Shah Monica R; Miller Leslie W; Russell Stuart D; Young James B; Califf Robert M; Nohria Anju
Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial.
Circulation. Heart failure 2008;1(3):170-7.
2008: Verma Anil; Meris Alessandra; Skali Hicham; Ghali Jalal K; Arnold J Malcolm O; Bourgoun Mikhail; Velazquez Eric J; McMurray John J V; Kober Lars; Pfeffer Marc A; Califf Robert M; Solomon Scott D
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
JACC. Cardiovascular imaging 2008;1(5):582-91.
2008: Peto Richard; Emberson Jonathan; Landray Martin; Baigent Colin; Collins Rory; Clare Robert; Califf Robert
Analyses of cancer data from three ezetimibe trials.
The New England journal of medicine 2008;359(13):1357-66.
2008: Smith P Brian; Benjamin Daniel K; Murphy M Dianne; Johann-Liang Rosemary; Iyasu Solomon; Gould Barbara; Califf Robert M; Li Jennifer S; Rodriguez William
Safety monitoring of drugs receiving pediatric marketing exclusivity.
Pediatrics 2008;122(3):e628-33.
2008: Brilakis Emmanouil S; de Lemos James A; Cannon Christopher P; Wiviott Stephen D; Murphy Sabina A; Morrow David A; Sabatine Marc S; Banerjee Subhash; Blazing Michael A; Califf Robert M; Braunwald Eugene
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
The American journal of cardiology 2008;102(5):552-8.
2008: Yau James M; Alexander John H; Hafley Gail; Mahaffey Kenneth W; Mack Michael J; Kouchoukos Nicholas; Goyal Abhinav; Peterson Eric D; Gibson C Michael; Califf Robert M; Harrington Robert A; Ferguson T Bruce;
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV).
The American journal of cardiology 2008;102(5):546-51.
2008: Reed Shelby D; Anstrom Kevin J; Seils Damon M; Califf Robert M; Schulman Kevin A
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs.
Health affairs (Project Hope) 2008;27(5):w360-70.
2008: Payne K A; Caro J J; Daley W L; Khan Z M; Ishak K J; Stark K; Purkayastha D; Flack J; Velázquez E; Nesbitt S; Morisky D; Califf R;
The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participants.
International journal of clinical practice 2008;62(9):1313-21.
2008: Szczech Lynda A; Barnhart Huiman X; Inrig Jula K; Reddan Donal N; Sapp Shelly; Califf Robert M; Patel Uptal D; Singh Ajay K
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.
Kidney international 2008;74(6):791-8.
2008: Li J S; Baker-Smith C M; Smith P B; Hasselblad V; Murphy M D; Califf R M; Benjamin D K
Racial differences in blood pressure response to angiotensin-converting enzyme inhibitors in children: a meta-analysis.
Clinical pharmacology and therapeutics 2008;84(3):315-9.
2008: Chan Mark Y; Mahaffey Kenneth W; Sun Lena J; Pieper Karen S; White Harvey D; Aylward Philip E; Ferguson James J; Califf Robert M; Roe Matthew T
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.
JACC. Cardiovascular interventions 2008;1(4):369-78.
2008: Anstrom Kevin J; Kong David F; Shaw Linda K; Califf Robert M; Kramer Judith M; Peterson Eric D; Rao Sunil V; Matchar David B; Mark Daniel B; Harrington Robert A; Eisenstein Eric L
Long-term clinical outcomes following coronary stenting.
Archives of internal medicine 2008;168(15):1647-55.
2008: Rao Sunil V; Califf Robert M; Kramer Judith M; Peterson Eric D; Gross Thomas P; Pepine Carl J; Williams David O; Donohoe Dennis; Waksman Ron; Mehran Roxana; Krucoff Mitchell W
Postmarket evaluation of breakthrough technologies.
American heart journal 2008;156(2):201-8.
2008: Califf Robert M; Kramer Judith M
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment.
Pharmacoepidemiology and drug safety 2008;17(8):782-6.
2008: Lopes Renato D; Alexander Karen P; Marcucci Gretchen; White Harvey D; Spinler Sarah; Col Jacques; Aylward Philip E; Califf Robert M; Mahaffey Kenneth W
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
European heart journal 2008;29(15):1827-33.
2008: Roe Matthew T; Chen Anita Y; Delong Elizabeth R; Boden William E; Calvin James E; Cairns Charles B; Smith Sidney C; Pollack Charles V; Brindis Ralph G; Califf Robert M; Gibler W Brian; Ohman E Magnus; Peterson Eric D
Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals.
American heart journal 2008;156(1):185-92.
2008: Leung Steve; Gallup Dianne; Mahaffey Kenneth W; Cohen Marc; Antman Elliott M; Goodman Shaun G; Harrington Robert A; Langer Anatoly; Aylward Philip; Ferguson James J; Califf Robert M;
Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
American heart journal 2008;156(1):177-84.
2008: Piccini Jonathan P; Patel Manesh R; Mahaffey Kenneth W; Fox Keith A A; Califf Robert M
Rivaroxaban, an oral direct factor Xa inhibitor.
Expert opinion on investigational drugs 2008;17(6):925-37.
2008: Klein Liviu; Massie Barry M; Leimberger Jeffrey D; O'Connor Christopher M; Piña Ileana L; Adams Kirkwood F; Califf Robert M; Gheorghiade Mihai;
Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
Circulation. Heart failure 2008;1(1):25-33.
2008: Prisant L Michael; Thomas Kevin L; Lewis Eldrin F; Huang Zhen; Francis Gary S; Weaver W Douglas; Pfeffer Marc A; McMurray John J V; Califf Robert M; Velazquez Eric J
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.
Journal of the American College of Cardiology 2008;51(19):1865-71.
2008: Chew Derek P; Mahaffey Kenneth W; White Harvey D; Huang Zhen; Hoekstra James W; Ferguson James J; Califf Robert M; Aylward Philip E
Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict.
American heart journal 2008;155(5):841-7.
2008: Jackson Kevin; Gersh Bernard J; Stockbridge Norman; Fleming Thomas R; Temple Robert; Califf Robert M; Connolly Stuart J; Wallentin Lars; Granger Christopher B;
Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005.
American heart journal 2008;155(5):829-40.
2008: Konstance Richard P; Eisenstein Eric L; Anstrom Kevin J; Shaw Linda K; Califf Robert M; Harrington Robert A; Matchar David B; Schulman Kevin A; Kong David F
Outcomes of second revascularization procedures after stent implantation.
Journal of medical systems 2008;32(2):177-86.
2008: Nohria Anju; Hasselblad Vic; Stebbins Amanda; Pauly Daniel F; Fonarow Gregg C; Shah Monica; Yancy Clyde W; Califf Robert M; Stevenson Lynne W; Hill James A
Cardiorenal interactions: insights from the ESCAPE trial.
Journal of the American College of Cardiology 2008;51(13):1268-74.
2008: Shah Monica R; Whellan David J; Peterson Eric D; Nohria Anju; Hasselblad Vic; Xue Zhenyi; Bowers Margaret T; O'Connor Christopher M; Califf Robert M; Stevenson Lynne W
Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of care.
American heart journal 2008;155(4):764.e1-5.
2008: Mielniczuk Lisa M; Pfeffer Marc A; Lewis Eldrin F; Blazing Michael A; de Lemos James A; Shui Amy; Mohanavelu Satish; Califf Robert M; Braunwald Eugene
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.
American heart journal 2008;155(4):725-31.
2008: Anderson Rachel E; Pfeffer Marc A; Thune Jens Jakob; McMurray John J V; Califf Robert M; Velazquez Eric; White Harvey D; Rouleau Jean L; Skali Hicham; Maggioni Aldo; Solomon Scott D
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2008;155(4):706-11.
2008: Best Patricia J M; Steinhubl Steven R; Berger Peter B; Dasgupta Arijit; Brennan Danielle M; Szczech Lynda A; Califf Robert M; Topol Eric J;
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
American heart journal 2008;155(4):687-93.
2008: Michener J Lloyd; Yaggy Susan; Lyn Michelle; Warburton Samuel; Champagne Mary; Black MaryAnn; Cuffe Michael; Califf Robert; Gilliss Catherine; Williams R Sanders; Dzau Victor J
Improving the health of the community: Duke's experience with community engagement.
Academic medicine : journal of the Association of American Medical Colleges 2008;83(4):408-13.
2008: Anavekar Nagesh S; Solomon Scott D; McMurray John J V; Maggioni Aldo; Rouleau Jean Lucien; Califf Robert; White Harvey; Kober Lars; Velazquez Eric; Pfeffer Marc A
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.
The American journal of cardiology 2008;101(7):925-9.
2008: Mehta Rajendra H; Rao Sunil V; Ohman E Magnus; Bates Eric R; Marcucci Gretchen; Zhang Min; Pieper Karen S; Armstrong Paul W; White Harvey D; Van de Werf Frans; Califf Robert M; Granger Christopher B
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.
European heart journal 2008;29(7):880-7.
2008: Benjamin Daniel K; Smith P Brian; Jadhav Pravin; Gobburu Jogarao V; Murphy M Dianne; Hasselblad Vic; Baker-Smith Carissa; Califf Robert M; Li Jennifer S
Pediatric antihypertensive trial failures: analysis of end points and dose range.
Hypertension 2008;51(4):834-40.
2008: Smith P Brian; Li Jennifer S; Murphy M Dianne; Califf Robert M; Benjamin Daniel K
Safety of placebo controls in pediatric hypertension trials.
Hypertension 2008;51(4):829-33.
2008: Califf Robert M
Review: PCI has lower risk for procedural stroke but higher risks for angina and repeated revascularization than CABG.
ACP journal club 2008;148(2):44.
2008: Lewis Eldrin F; Velazquez Eric J; Solomon Scott D; Hellkamp Anne S; McMurray John J V; Mathias Jasmine; Rouleau Jean-Lucien; Maggioni Aldo P; Swedberg Karl; Kober Lars; White Harvey; Dalby Anthony J; Francis Gary S; Zannad Faiez; Califf Robert M; Pfeffer Marc A
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
European heart journal 2008;29(6):748-56.
2008: Anavekar Nagesh S; Skali Hicham; Bourgoun Mikhail; Ghali Jalal K; Kober Lars; Maggioni Aldo P; McMurray John J V; Velazquez Eric; Califf Robert; Pfeffer Marc A; Solomon Scott D
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
The American journal of cardiology 2008;101(5):607-12.
2008: Jolicoeur E Marc; Ohman E Magnus; Temple Robert; Stockbridge Norman; Smith Sidney; Mark Daniel; Califf Robert M; Henry Timothy D; Chaitman Bernard R; Granger Christopher B;
Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues.
American heart journal 2008;155(3):435-44.
2008: Mahaffey Kenneth W; Yang Qinghong; Pieper Karen S; Antman Elliott M; White Harvey D; Goodman Shaun G; Cohen Marc; Kleiman Neal S; Langer Anatoly; Aylward Philip E; Col Jacques J; Reist Craig; Ferguson James J; Califf Robert M;
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
Journal of general internal medicine 2008;23(3):310-6.
2008: Olenchock Stephen A; Karmpaliotis Dimitri; Gibson William J; Murphy Sabina A; Southard Matthew C; Ciaglo Lauren; Buros Jacqueline; Mack Michael J; Alexander John H; Harrington Robert A; Califf Robert M; Kouchoukos Nicholas T; Ferguson T Bruce; Gibson C Michael
Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
The Annals of thoracic surgery 2008;85(2):520-4.
2008: Magee Mitchell J; Alexander John H; Hafley Gail; Ferguson T Bruce; Gibson C Michael; Harrington Robert A; Peterson Eric D; Califf Robert M; Kouchoukos Nicholas T; Herbert Morley A; Mack Michael J;
Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
The Annals of thoracic surgery 2008;85(2):494-9; discussion 499-500.
2008: Rao Sunil V; Kaul Padma R; Liao Lawrence; Armstrong Paul W; Ohman E Magnus; Granger Christopher B; Califf Robert M; Harrington Robert A; Eisenstein Eric L; Mark Daniel B
Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 2008;155(2):369-74.
2008: Chew Derek P; Huang Zhen; Pieper Karen S; White Harvey; Mahaffey Kenneth W; Ferguson James J; Califf Robert M; Aylward Philip G
Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
American heart journal 2008;155(2):239-44.
2008: Harrington Robert A; Hasselblad Vic; Califf Robert M
Defining and utilizing surrogates in the evaluation of coronary stents: what do we really want and need to know?
Journal of the American College of Cardiology 2008;51(1):33-6.
2008: Rao Sunil V; Chiswell Karen; Sun Jie-Lena; Granger Christopher B; Newby L Kristin; Van de Werf Frans; White Harvey D; Armstong Paul W; Califf Robert M; Harrington Robert A
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes.
The American journal of cardiology 2008;101(1):25-29.
2008: Berger Jeffrey S; Stebbins Amanda; Granger Christopher B; Ohman Eric M; Armstrong Paul W; Van de Werf Frans; White Harvey D; Simes R John; Harrington Robert A; Califf Robert M; Peterson Eric D
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.
Circulation 2008;117(2):192-9.
2008: Thomas Kevin L; Al-Khatib Sana M; Lokhnygina Yuliya; Solomon Scott D; Kober Lars; McMurray John J V; Califf Robert M; Velazquez Eric J
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
American heart journal 2008;155(1):87-93.
2008: Thune Jens J; Signorovitch James; Kober Lars; Velazquez Eric J; McMurray John J V; Califf Robert M; Maggioni Aldo P; Rouleau Jean L; Howlett Jonathan; Zelenkofske Steven; Pfeffer Marc A; Solomon Scott D
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Hypertension 2008;51(1):48-54.
2008: Weinfurt Kevin P; Seils Damon M; Tzeng Janice P; Lin Li; Schulman Kevin A; Califf Robert M
Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents.
PloS one 2008;3(5):e2128.
2008: Eisenstein Eric L; Collins Rory; Cracknell Beena S; Podesta Oscar; Reid Elizabeth D; Sandercock Peter; Shakhov Yuriy; Terrin Michael L; Sellers Mary Ann; Califf Robert M; Granger Christopher B; Diaz Rafael
Sensible approaches for reducing clinical trial costs.
Clinical trials (London, England) 2008;5(1):75-84.
2008: Yusuf Salim; Bosch Jackie; Devereaux Philip J; Collins Rory; Baigent Colin; Granger Christopher; Califf Robert; Temple Robert
Sensible guidelines for the conduct of large randomized trials.
Clinical trials (London, England) 2008;5(1):38-9.
2007: Tricoci Pierluigi; Lokhnygina Yuliya; Berdan Lisa G; Steinhubl Steven R; Gulba Dietrich C; White Harvey D; Kleiman Neal S; Aylward Philip E; Langer Anatoly; Califf Robert M; Ferguson James J; Antman Elliott M; Newby L Kristin; Harrington Robert A; Goodman Shaun G; Mahaffey Kenneth W
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Circulation 2007;116(23):2669-77.
2007: Al-Khatib Sana M; Shaw Linda K; O'Connor Christopher; Kong Melissa; Califf Robert M
Incidence and predictors of sudden cardiac death in patients with diastolic heart failure.
Journal of cardiovascular electrophysiology 2007;18(12):1231-5.
2007: de Lemos James A; Morrow David A; Blazing Michael A; Jarolim Petr; Wiviott Stephen D; Sabatine Marc S; Califf Robert M; Braunwald Eugene
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Journal of the American College of Cardiology 2007;50(22):2117-24.
2007: Califf Robert M; Mehta Rajendra H; Peterson Eric D
Clinical quality in non-ST-elevation acute coronary syndromes.
The American journal of medicine 2007;120(11):930-5.
2007: Shah Monica R; Hasselblad Vic; Tasissa Gudaye; Christenson Robert H; Binanay Cynthia; O'Connor Christopher M; Ohman E Magnus; Stevenson Lynne W; Califf Robert M
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
The American journal of cardiology 2007;100(9):1427-33.
2007: Mark Daniel B; Van de Werf Frans J; Simes R John; White Harvey D; Wallentin Lars C; Califf Robert M; Armstrong Paul W;
Cardiovascular disease on a global scale: defining the path forward for research and practice.
European heart journal 2007;28(21):2678-84.
2007: Singh Mandeep; White Jennifer; Hasdai David; Hodgson Patricia K; Berger Peter B; Topol Eric J; Califf Robert M; Holmes David R
Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
Journal of the American College of Cardiology 2007;50(18):1752-8.
2007: Bennett-Guerrero Elliott; Veldman Tim H; Doctor Allan; Telen Marilyn J; Ortel Thomas L; Reid T Scott; Mulherin Melissa A; Zhu Hongmei; Buck Raymond D; Califf Robert M; McMahon Timothy J
Evolution of adverse changes in stored RBCs.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(43):17063-8.
2007: Murphy Sabina A; Cannon Christopher P; Wiviott Stephen D; de Lemos James A; Blazing Michael A; McCabe Carolyn H; Califf Robert M; Braunwald Eugene
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
The American journal of cardiology 2007;100(7):1047-51.
2007: Mehta Rajendra H; Greenbaum Adam B; Lokhnygina Yuliya; Newby L Kristin; Van De Werf Frans; Armstrong Paul W; Pieper Karen S; Califf Robert M; Granger Christopher B; Harrington Robert A
Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
Journal of interventional cardiology 2007;20(5):299-306.
2007: Hasselblad Vic; Gattis Stough Wendy; Shah Monica R; Lokhnygina Yuliya; O'Connor Christopher M; Califf Robert M; Adams Kirkwood F
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(10):1064-9.
2007: Anderson Jeffrey L; Adams Cynthia D; Antman Elliott M; Bridges Charles R; Califf Robert M; Casey Donald E; Chavey William E; Fesmire Francis M; Hochman Judith S; Levin Thomas N; Lincoff A Michael; Peterson Eric D; Theroux Pierre; Wenger Nanette Kass; Wright R Scott; Smith Sidney C; Jacobs Alice K; Adams Cynthia D; Anderson Jeffrey L; Antman Elliott M; Halperin Jonathan L; Hunt Sharon A; Krumholz Harlan M; Kushner Frederick G; Lytle Bruce W; Nishimura Rick; Ornato Joseph P; Page Richard L; Riegel Barbara;
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Journal of the American College of Cardiology 2007;50(7):e1-e157.
2007: Anderson Jeffrey L; Adams Cynthia D; Antman Elliott M; Bridges Charles R; Califf Robert M; Casey Donald E; Chavey William E; Fesmire Francis M; Hochman Judith S; Levin Thomas N; Lincoff A Michael; Peterson Eric D; Theroux Pierre; Wenger Nanette Kass; Wright R Scott; Smith Sidney C; Jacobs Alice K; Halperin Jonathan L; Hunt Sharon A; Krumholz Harlan M; Kushner Frederick G; Lytle Bruce W; Nishimura Rick; Ornato Joseph P; Page Richard L; Riegel Barbara;
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Circulation 2007;116(7):e148-304.
2007: Wong Cheuk-Kit; Newby L Kristin; Bhapker Manju V; Aylward Phil E; Pfisterer Matthias; Alexander Karen P; Armstrong Paul W; Hochman Judith S; Van de Werf Frans; Califf Robert M; White Harvey D;
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
American heart journal 2007;154(2):313-21.
2007: Westerhout Cynthia M; Gnarpe Judy; Chang Wei-Ching; FitzPatrick Susan; Barnathan Elliot S; Boersma Eric; Califf Robert M; Wallentin Lars; Simoons Maarten L; Armstrong Paul W;
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.
American heart journal 2007;154(2):306-12.
2007: Tilson H H; Madre L K; Califf R M
Role of the centers for education and research on therapeutics (CERTs) in pharmacovigilance and proper use of therapeutics.
Clinical pharmacology and therapeutics 2007;82(2):118-21.
2007: Li Jennifer S; Yow Eric; Berezny Katherine Y; Rhodes John F; Bokesch Paula M; Charpie John R; Forbus Geoffrey A; Mahony Lynn; Boshkov Lynn; Lambert Virginie; Bonnet Damien; Michel-Behnke Ina; Graham Thomas P; Takahashi Masato; Jaggers James; Califf Robert M; Rakhit Amit; Fontecave Sylvie; Sanders Stephen P
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?
Circulation 2007;116(3):293-7.
2007: Jiang Wei; Kuchibhatla Maragatha; Clary Greg L; Cuffe Michael S; Christopher Eric J; Alexander Jude D; Califf Robert M; Krishnan Ranga R; O'Connor Christopher M
Relationship between depressive symptoms and long-term mortality in patients with heart failure.
American heart journal 2007;154(1):102-8.
2007: Barbagelata Alejandro; Perna Eduardo R; Clemmensen Peter; Uretsky Barry F; Canella Juan P Cimbaro; Califf Robert M; Granger Christopher B; Adams George L; Merla Ramanna; Birnbaum Yochai
Time to reperfusion in acute myocardial infarction. It is time to reduce it!
Journal of electrocardiology 2007;40(3):257-64.
2007: Sanders Gillian D; Al-Khatib Sana M; Berliner Elise; Bigger J Thomas; Buxton Alfred E; Califf Robert M; Carlson Mark; Curtis Anne B; Curtis Jeptha P; Domanski Michael; Fain Eric; Gersh Bernard J; Gold Michael R; Goldberger Jeffrey; Haghighi-Mood Ali; Hammill Stephen C; Harder Joel; Healey Jeffrey; Hlatky Mark A; Hohnloser Stefan H; Lee Kerry L; Mark Daniel B; Mitchell Brent; Phurrough Steve; Prystowsky Eric; Smith Joseph M; Stockbridge Norman; Temple Robert;
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.
American heart journal 2007;153(6):951-9.
2007: Al-Khatib Sana M; Sanders Gillian D; Bigger J Thomas; Buxton Alfred E; Califf Robert M; Carlson Mark; Curtis Anne; Curtis Jeptha; Fain Eric; Gersh Bernard J; Gold Michael R; Haghighi-Mood Ali; Hammill Stephen C; Healey Jeff; Hlatky Mark; Hohnloser Stefan; Kim Raymond J; Lee Kerry; Mark Daniel; Mianulli Marcus; Mitchell Brent; Prystowsky Eric N; Smith Joseph; Steinhaus David; Zareba Wojciech;
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death.
American heart journal 2007;153(6):941-50.
2007: Mehta Rajendra H; Peterson Eric D; Califf Robert M
Performance measures have a major effect on cardiovascular outcomes: a review.
The American journal of medicine 2007;120(5):398-402.
2007: Rao Sunil V; Eikelboom John A; Granger Christopher B; Harrington Robert A; Califf Robert M; Bassand Jean-Pierre
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal 2007;28(10):1193-204.
2007: Miller Chadwick D; Banerjee Anindita; Mahaffey Kenneth W; Kontos Michael C; Fermann Gregory; Pollack Charles V; Antman Elliott; Aylward Philip; Goodman Shaun G; Santos Renato; Ferguson James J; Califf Robert M; Hoekstra James W
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial.
European heart journal 2007;28(9):1079-84.
2007: Turer Aslan T; Mahaffey Kenneth W; Compton Kate L; Califf Robert M; Schulman Kevin A
Publication or presentation of results from multicenter clinical trials: evidence from an academic medical center.
American heart journal 2007;153(4):674-80.
2007: Hernández Adrián V; Westerhout Cynthia M; Steyerberg Ewout W; Ioannidis John P A; Bueno Héctor; White Harvey; Theroux Pierre; Moliterno David J; Armstrong Paul W; Califf Robert M; Wallentin Lars C; Simoons Maarten L; Boersma Eric
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups.
Heart (British Cardiac Society) 2007;93(4):450-5.
2007: Mehta Rajendra H; Califf Robert M; Yang Qinghong; Pieper Karen S; White Harvey D; Ohman E Magnus; Harrington Robert A; Granger Christopher B
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.
The American journal of cardiology 2007;99(6):793-6.
2007: Stephenson Kent; Skali Hicham; McMurray John J V; Velazquez Eric J; Aylward Philip G; Kober Lars; Van de Werf Frans; White Harvey D; Pieper Karen S; Califf Robert M; Solomon Scott D; Pfeffer Marc A
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(3):308-13.
2007: Bethel M Angelyn; Califf Robert M
Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease.
The American journal of cardiology 2007;99(5):726-31.
2007: Rankin J Scott; Tuttle Robert H; Wechsler Andrew S; Teichmann Tracey L; Glower Donald D; Califf Robert M
Techniques and benefits of multiple internal mammary artery bypass at 20 years of follow-up.
The Annals of thoracic surgery 2007;83(3):1008-14; discussion 1014-5.
2007: Goyal Abhinav; Alexander John H; Hafley Gail E; Graham Stacy H; Mehta Rajendra H; Mack Michael J; Wolf Randall K; Cohn Lawrence H; Kouchoukos Nicholas T; Harrington Robert A; Gennevois Daniel; Gibson C Michael; Califf Robert M; Ferguson T Bruce; Peterson Eric D;
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
The Annals of thoracic surgery 2007;83(3):993-1001.
2007: Li Jennifer S; Eisenstein Eric L; Grabowski Henry G; Reid Elizabeth D; Mangum Barry; Schulman Kevin A; Goldsmith John V; Murphy M Dianne; Califf Robert M; Benjamin Daniel K
Economic return of clinical trials performed under the pediatric exclusivity program.
JAMA : the journal of the American Medical Association 2007;297(5):480-8.
2007: Wollert Kai C; Kempf Tibor; Peter Timo; Olofsson Sylvia; James Stefan; Johnston Nina; Lindahl Bertil; Horn-Wichmann Rüdiger; Brabant Georg; Simoons Maarten L; Armstrong Paul W; Califf Robert M; Drexler Helmut; Wallentin Lars
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
Circulation 2007;115(8):962-71.
2007: Mahaffey Kenneth W; Roe Matthew T; Kilaru Rakhi; Alexander John H; Van de Werf Frans; Califf Robert M; Simoons Maarten L; Topol Eric J; Harrington Robert A
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
European heart journal 2007;28(4):425-32.
2007: Echols Melvin R; Mahaffey Kenneth W; Banerjee Anindita; Pieper Karen S; Stebbins Amanda; Lansky Alexandra; Cohen Mauricio G; Velazquez Eric; Santos Renato; Newby L Kristin; Gurfinkel Enrique P; Biasucci Luigi; Ferguson James J; Califf Robert M
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial).
The American journal of cardiology 2007;99(3):315-21.
2007: Mehta Rajendra H; Califf Robert M; Garg Jyotsna; White Harvey D; Van de Werf Frans; Armstrong Paul W; Pieper Karen S; Topol Eric J; Granger Christopher B
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction.
European heart journal 2007;28(4):415-24.
2007: Califf Robert M; Harrington Robert A; Madre Leanne K; Peterson Eric D; Roth Deborah; Schulman Kevin A
Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics.
Health affairs (Project Hope) 2007;26(1):62-74.
2007: Eisenstein Eric L; Anstrom Kevin J; Kong David F; Shaw Linda K; Tuttle Robert H; Mark Daniel B; Kramer Judith M; Harrington Robert A; Matchar David B; Kandzari David E; Peterson Eric D; Schulman Kevin A; Califf Robert M
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
JAMA : the journal of the American Medical Association 2007;297(2):159-68.
2007: Cantor Warren J; Mahaffey Kenneth W; Huang Zhen; Das Pranab; Gulba Dietrich C; Glezer Stanislav; Gallo Richard; Ducas John; Cohen Marc; Antman Elliott M; Langer Anatoly; Kleiman Neal S; White Harvey D; Chisholm Robert J; Harrington Robert A; Ferguson James J; Califf Robert M; Goodman Shaun G
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(1):73-83.
2007: Califf Robert M;
Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics.
Pharmacoepidemiology and drug safety 2007;16(1):5-16.
2006: Echols Melvin R; Felker G Michael; Thomas Kevin L; Pieper Karen S; Garg Jyotsna; Cuffe Michael S; Gheorghiade Mihai; Califf Robert M; O'Connor Christopher M
Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.
Journal of cardiac failure 2006;12(9):684-8.
2006: Harrington Robert A; Califf Robert M
Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried?
Journal of the American College of Cardiology 2006;48(12):2592-5.
2006: White Harvey D; Kleiman Neal S; Mahaffey Kenneth W; Lokhnygina Yuliya; Pieper Karen S; Chiswell Karen; Cohen Marc; Harrington Robert A; Chew Derek P; Petersen John L; Berdan Lisa G; Aylward Philip E G; Nessel Christopher C; Ferguson James J; Califf Robert M
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
American heart journal 2006;152(6):1042-50.
2006: Westerhout Cynthia M; Hernández Adrián V; Steyerberg Ewout W; Bueno Héctor; White Harvey; Théroux Pierre; Moliterno David J; Armstrong Paul W; Califf Robert M; Wallentin Lars C; Simoons Maarten L; Boersma Eric
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal 2006;27(24):2956-61.
2006: Mehta Rajendra H; Roe Matthew T; Chen Anita Y; Lytle Barbara L; Pollack Charles V; Brindis Ralph G; Smith Sidney C; Harrington Robert A; Fintel Dan; Fraulo Elizabeth S; Califf Robert M; Gibler W Brian; Ohman E Magnus; Peterson Eric D
Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
Archives of internal medicine 2006;166(18):2027-34.
2006: Cohen Marc; Mahaffey Kenneth W; Pieper Karen; Pollack Charles V; Antman Elliott M; Hoekstra James; Goodman Shaun G; Langer Anatoly; Col Jacques J; White Harvey D; Califf Robert M; Ferguson James J;
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
Journal of the American College of Cardiology 2006;48(7):1346-54.
2006: Smith Peter K; Califf Robert M; Tuttle Robert H; Shaw Linda K; Lee Kerry L; Delong Elizabeth R; Lilly R Eric; Sketch Michael H; Peterson Eric D; Jones Robert H
Selection of surgical or percutaneous coronary intervention provides differential longevity benefit.
The Annals of thoracic surgery 2006;82(4):1420-8; discussion 1428-9.
2006: Davidson Karina W; Kupfer David J; Bigger J Thomas; Califf Robert M; Carney Robert M; Coyne James C; Czajkowski Susan M; Frank Ellen; Frasure-Smith Nancy; Freedland Kenneth E; Froelicher Erika S; Glassman Alexander H; Katon Wayne J; Kaufmann Peter G; Kessler Ronald C; Kraemer Helena C; Krishnan K Ranga R; Lespérance François; Rieckmann Nina; Sheps David S; Suls Jerry M
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report.
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2006;32(2):121-6.
2006: Køber Lars; Swedberg Karl; McMurray John J V; Pfeffer Marc A; Velazquez Eric J; Diaz Rafael; Maggioni Aldo P; Mareev Viatcheslav; Opolski Grzegorz; Van de Werf Frans; Zannad Faiez; Ertl Georg; Solomon Scott D; Zelenkofske Steven; Rouleau Jean-Lucien; Leimberger Jeffrey D; Califf Robert M
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(6):591-8.
2006: Davidson Karina W; Kupfer David J; Bigger J Thomas; Califf Robert M; Carney Robert M; Coyne James C; Czajkowski Susan M; Frank Ellen; Frasure-Smith Nancy; Freedland Kenneth E; Froelicher Erika S; Glassman Alexander H; Katon Wayne J; Kaufmann Peter G; Kessler Ronald C; Kraemer Helena C; Krishnan K Ranga R; Lespérance François; Rieckmann Nina; Sheps David S; Suls Jerry M;
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report.
Psychosomatic medicine 2006;68(5):645-50.
2006: James Stefan K; Lindbäck Johan; Tilly Johanna; Siegbahn Agneta; Venge Per; Armstrong Paul; Califf Robert; Simoons Maarten L; Wallentin Lars; Lindahl Bertil
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2006;48(6):1146-54.
2006: Benjamin Daniel K; Smith Philip Brian; Murphy M Dianne; Roberts Rosemary; Mathis Lisa; Avant Debbie; Califf Robert M; Li Jennifer S
Peer-reviewed publication of clinical trials completed for pediatric exclusivity.
JAMA : the journal of the American Medical Association 2006;296(10):1266-73.
2006: Reed Shelby D; Califf Robert M; Schulman Kevin A
How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
Health affairs (Project Hope) 2006;25(5):1309-17.
2006: de Lemos James A; Wiviott Stephen D; Murphy Sabina A; Blazing Michael A; Lewis Eldrin F; Califf Robert M; Pfeffer Marc A; Braunwald Eugene
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial.
The American journal of cardiology 2006;98(6):739-42.
2006: Grandis Jennifer R; Battey James F; Califf Robert M; Chole Richard A; Gantz Bruce J; Gates George A; Gorelic Lester; Hannley Maureen T; Hardwick Kevin S; Harris Jeffrey P; Kapoor Wishwa N; Lai Stephen Y; Lalwani Anil K; Minor Lloyd B; Nadol Joseph P; Post J Christopher; Roland Peter S; Schechter Alan M; Schuller David E; Sklare Daniel A; Wackym P Ashley; Weber Randal S; Weymuller Ernest A; Wolf Gregory T; Woodson Gayle E
Research education and training in otolaryngology: meeting summary and research opportunities.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2006;135(3):361-7.
2006: Westerhout Cynthia M; Fu Yuling; Lauer Michael S; James Stefan; Armstrong Paul W; Al-Hattab Eyad; Califf Robert M; Simoons Maarten L; Wallentin Lars; Boersma Eric;
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
Journal of the American College of Cardiology 2006;48(5):939-47.
2006: Reed Shelby D; McMurray John J V; Velazquez Eric J; Schulman Kevin A; Califf Robert M; Kober Lars; Maggioni Aldo P; Van de Werf Frans; White Harvey D; Diaz Rafael; Mareev Viatcheslav; Murin Jan;
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2006;152(3):500-8.
2006: Menon Sharad; Berezny Katherine Y; Kilaru Rakhi; Benjamin Daniel K; Kay Joseph D; Hazan Lydie; Portman Ronald; Hogg Ronald; Deitchman David; Califf Robert M; Li Jennifer S
Racial differences are seen in blood pressure response to fosinopril in hypertensive children.
American heart journal 2006;152(2):394-9.
2006: Whellan David J; Tuttle Robert H; Velazquez Eric J; Shaw Linda K; Jollis James G; Ellis Wendell; O'Connor Christopher M; Califf Robert M; Borges-Neto Salvador
Predicting significant coronary artery disease in patients with left ventricular dysfunction.
American heart journal 2006;152(2):340-7.
2006: Goodman Shaun G; Fu Yuling; Langer Anatoly; Barr Aiala; Tan Mary; Wagner Galen S; Barbagelata Alejandro; Sgarbossa Elena B; Birnbaum Yochai; Granger Christopher B; Califf Robert M; Van de Werf Frans; Topol Eric J; Armstrong Paul W;
The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experience.
American heart journal 2006;152(2):277-84.
2006: Morrow David A; de Lemos James A; Sabatine Marc S; Wiviott Stephen D; Blazing Michael A; Shui Amy; Rifai Nader; Califf Robert M; Braunwald Eugene
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
Circulation 2006;114(4):281-8.
2006: Janardhanan Rajesh; Kenchaiah Satish; Velazquez Eric J; Park Yuhyun; McMurray John J V; Weaver W Douglas; Finn Peter V; White Harvey D; Marin-Neto Jose A; O'Connor Chris; Pfeffer Marc A; Califf Robert M; Solomon Scott D;
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
American heart journal 2006;152(1):183-9.
2006: Califf Robert M;
Evaluation of diagnostic imaging technologies and therapeutics devices: better information for better decisions: proceedings of a multidisciplinary workshop.
American heart journal 2006;152(1):50-8.
2006: Mehta Rajendra H; Honeycutt Emily; Peterson Eric D; Granger Christopher B; Halabi Abdul R; Shaw Linda K; Smith Peter K; Califf Robert M; Harrington Robert A; Sketch Michael H
Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
Circulation 2006;114(1 Suppl):I396-401.
2006: Alexander Karen P; Newby Laura Kristin; Bhapkar Manju V; White Harvey D; Hochman Judith S; Pfisterer Matthias E; Moliterno David J; Peterson Eric D; Van de Werf Frans; Armstrong Paul W; Califf Robert M;
International variation in invasive care of the elderly with acute coronary syndromes.
European heart journal 2006;27(13):1558-64.
2006: Roe Matthew T; Peterson Eric D; Newby L Kristin; Chen Anita Y; Pollack Charles V; Brindis Ralph G; Harrington Robert A; Christenson Robert H; Smith Sidney C; Califf Robert M; Braunwald Eugene; Gibler W Brian; Ohman E Magnus
The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 2006;151(6):1205-13.
2006: Bushnell Cheryl D; Griffin Jeffrey; Newby L Kristin; Goldstein Larry B; Mahaffey Kenneth W; Graffagnino Carmelo A; Harrington Robert A; White Harvey D; Simes R John; Califf Robert M; Topol Eric J; Easton J Donald
Statin use and sex-specific stroke outcomes in patients with vascular disease.
Stroke; a journal of cerebral circulation 2006;37(6):1427-31.
2006: LaPointe Nancy M Allen; DeLong Elizabeth R; Chen Anita; Hammill Bradley G; Muhlbaier Lawrence H; Califf Robert M; Kramer Judith M
Multifaceted intervention to promote beta-blocker use in heart failure.
American heart journal 2006;151(5):992-8.
2006: O'Shea J Conor; Califf Robert M
24-hour ambulatory blood pressure monitoring.
American heart journal 2006;151(5):962-8.
2006: Kaul Padma; Chang Wei-Ching; Lincoff A Michael; Aylward Philip; Betriu Amadeo; Bode Christoph; Califf Robert M; Ohman E Magnus; Guetta Victor; Steg P Gabriel; Van de Werf Frans; Armstrong Paul W
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial.
European heart journal 2006;27(10):1198-206.
2006: Begg Colin B; Brawley Otis; Califf Robert M; Demets David L; Ellenberg Susan S; Kaplan Richard S
Marketing drugs too early in testing.
Science (New York, N.Y.) 2006;312(5771):195.
2006: Califf Robert M
Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above?
JAMA : the journal of the American Medical Association 2006;295(13):1579-80.
2006: Wiviott Stephen D; de Lemos James A; Cannon Christopher P; Blazing Michael; Murphy Sabina A; McCabe Carolyn H; Califf Robert; Braunwald Eugene
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Circulation 2006;113(11):1406-14.
2006: Patel Manesh R; Donahue Mark; Wilson Peter W F; Califf Robert M
Clinical trial issues in weight-loss therapy.
American heart journal 2006;151(3):633-42.
2006: Orlandini Andrés; Díaz Rafael; Wojdyla Daniel; Pieper Karen; Van de Werf Frans; Granger Christopher B; Harrington Robert A; Boersma Eric; Califf Robert M; Armstrong Paul; White Harvey; Simes John; Paolasso Ernesto
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.
European heart journal 2006;27(5):527-33.
2006: Rao Sunil V; O'Grady Kristi; Pieper Karen S; Granger Christopher B; Newby L Kristin; Mahaffey Kenneth W; Moliterno David J; Lincoff A Michael; Armstrong Paul W; Van de Werf Frans; Califf Robert M; Harrington Robert A
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
Journal of the American College of Cardiology 2006;47(4):809-16.
2006: McMurray John; Solomon Scott; Pieper Karen; Reed Shelby; Rouleau Jean; Velazquez Eric; White Harvey; Howlett Jonathan; Swedberg Karl; Maggioni Aldo; Køber Lars; Van de Werf Frans; Califf Rob; Pfeffer Marc
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Journal of the American College of Cardiology 2006;47(4):726-33.
2006: Patel Manesh R; Meine Trip J; Lindblad Lauren; Griffin Jeffrey; Granger Christopher B; Becker Richard C; Van de Werf Frans; White Harvey; Califf Robert M; Harrington Robert A
Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction.
American heart journal 2006;151(2):316-22.
2006: James Stefan K; Lindahl Bertil; Timmer Jorik R; Ottervanger Jan Paul; Siegbahn Agneta; Stridsberg Mats; Armstrong Paul; Califf Robert; Wallentin Lars; Simoons Maarten L
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
The American journal of cardiology 2006;97(2):167-72.
2006: Mehta Rajendra H; Marks David; Califf Robert M; Sohn SeeHyang; Pieper Karen S; Van de Werf Frans; Peterson Eric D; Ohman E Magnus; White Harvey D; Topol Eric J; Granger Christopher B
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction.
The American journal of medicine 2006;119(1):70.e1-8.
2006: Newby L Kristin; LaPointe Nancy M Allen; Chen Anita Y; Kramer Judith M; Hammill Bradley G; DeLong Elizabeth R; Muhlbaier Lawrence H; Califf Robert M
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease.
Circulation 2006;113(2):203-12.
2006: Kauf Teresa L; Velazquez Eric J; Crosslin David R; Weaver W Douglas; Diaz Rafael; Granger Christopher B; McMurray John J V; Rouleau Jean-Lucien; Aylward Philip E; White Harvey D; Califf Robert M; Schulman Kevin A
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
American heart journal 2006;151(1):206-12.
2006: Galla John M; Mahaffey Kenneth W; Sapp Shelly K; Alexander John H; Roe Matthew T; Ohman E Magnus; Granger Christopher B; Armstrong Paul W; Harrington Robert A; White Harvey D; Simoons Maarten L; Newby L Kristin; Califf Robert M; Topol Eric J
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
American heart journal 2006;151(1):16-24.
2006: Califf Robert M
Clinical trials bureaucracy: unintended consequences of well-intentioned policy.
Clinical trials (London, England) 2006;3(6):496-502.
2006: Califf Robert M
Translating clinical trials into practice.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2006;33(2):192-6.
2006: Heitner John; Lotfi Mat; Harrison J Kevin; Cabell Christopher; Klem Igor; Banko Lesan; Kim Raymond J; Califf Robert M
Where's the flap?
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2006;8(3):549-50.
2005: Morrow David A; de Lemos James A; Blazing Michael A; Sabatine Marc S; Murphy Sabina A; Jarolim Petr; White Harvey D; Fox Keith A A; Califf Robert M; Braunwald Eugene;
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
JAMA : the journal of the American Medical Association 2005;294(22):2866-71.
2005: Mahaffey Kenneth W; Cohen Marc; Garg Jyotsna; Antman Elliott; Kleiman Neal S; Goodman Shaun G; Berdan Lisa G; Reist Craig J; Langer Anatoly; White Harvey D; Aylward Philip E; Col Jacques J; Ferguson James J; Califf Robert M;
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA : the journal of the American Medical Association 2005;294(20):2594-600.
2005: White Harvey D; Aylward Philip E G; Huang Zhen; Dalby Anthony J; Weaver W Douglas; Barvik Ståle; Marin-Neto José Antonio; Murin Jan; Nordlander Rolf O; van Gilst Wiek H; Zannad Faiez; McMurray John J V; Califf Robert M; Pfeffer Marc A;
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation 2005;112(22):3391-9.
2005: Shah Monica R; Claise Karen A; Bowers Margaret T; Bhapkar Manjushri; Little Julie; Nohria Anju; Gaulden Laura H; McKee Vickie K; Cozart Kara L; Mancinelli Karen L; Daniels Helen; Kinard Tesca; Stevenson Lynne W; Mancini Donna M; O'Connor Christopher M; Califf Robert M
Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial.
American heart journal 2005;150(5):893-8.
2005: Alexander John H; Hafley Gail; Harrington Robert A; Peterson Eric D; Ferguson T Bruce; Lorenz Todd J; Goyal Abhinav; Gibson Michael; Mack Michael J; Gennevois Daniel; Califf Robert M; Kouchoukos Nicholas T;
Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;294(19):2446-54.
2005: Rao Sunil V; O'Grady Kristi; Pieper Karen S; Granger Christopher B; Newby L Kristin; Van de Werf Frans; Mahaffey Kenneth W; Califf Robert M; Harrington Robert A
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.
The American journal of cardiology 2005;96(9):1200-6.
2005: Hernandez Adrian F; Velazquez Eric J; Solomon Scott D; Kilaru Rakhi; Diaz Rafael; O'Connor Christopher M; Ertl George; Maggioni Aldo P; Rouleau Jean-Lucien; van Gilst Wiek; Pfeffer Marc A; Califf Robert M;
Left ventricular assessment in myocardial infarction: the VALIANT registry.
Archives of internal medicine 2005;165(18):2162-9.
2005: Barbagelata Alejandro; Di Carli Marcelo F; Califf Robert M; Garg Jyotsna; Birnbaum Yochai; Grinfeld Liliana; Gibbons Raymond J; Granger Christopher B; Goodman Shaun G; Wagner Galen S; Mahaffey Kenneth W;
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial.
American heart journal 2005;150(4):659-65.
2005: Alexander John H; Ferguson T Bruce; Joseph Diane M; Mack Michael J; Wolf Randall K; Gibson C Michael; Gennevois Daniel; Lorenz Todd J; Harrington Robert A; Peterson Eric D; Lee Kerry L; Califf Robert M; Kouchoukos Nicholas T;
The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.
American heart journal 2005;150(4):643-9.
2005: Shah Monica R; Hasselblad Vic; Stevenson Lynne W; Binanay Cynthia; O'Connor Christopher M; Sopko George; Califf Robert M
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials.
JAMA : the journal of the American Medical Association 2005;294(13):1664-70.
2005: Binanay Cynthia; Califf Robert M; Hasselblad Vic; O'Connor Christopher M; Shah Monica R; Sopko George; Stevenson Lynne W; Francis Gary S; Leier Carl V; Miller Leslie W;
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.
JAMA : the journal of the American Medical Association 2005;294(13):1625-33.
2005: McMahon Timothy J; Ahearn Gregory S; Moya Martin P; Gow Andrew J; Huang Yuh-Chin T; Luchsinger Benjamin P; Nudelman Raphael; Yan Yun; Krichman Abigail D; Bashore Thomas M; Califf Robert M; Singel David J; Piantadosi Claude A; Tapson Victor F; Stamler Jonathan S
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(41):14801-6.
2005: Reddan Donal N; Szczech Lynda; Bhapkar Manjushri V; Moliterno David J; Califf Robert M; Ohman E Magnus; Berger Peter B; Hochman Judith S; Van de Werf Frans; Harrington Robert A; Newby L Kristin
Renal function, concomitant medication use and outcomes following acute coronary syndromes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(10):2105-12.
2005: Savonitto Stefano; Cohen Mauricio G; Politi Alessandro; Hudson Michael P; Kong David F; Huang Yao; Pieper Karen S; Mauri Francesco; Wagner Galen S; Califf Robert M; Topol Eric J; Granger Christopher B
Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes.
European heart journal 2005;26(20):2106-13.
2005: Szummer Karolina E; Solomon Scott D; Velazquez Eric J; Kilaru Rakhi; McMurray John; Rouleau Jean-Lucien; Mahaffey Kenneth W; Maggioni Aldo P; Califf Robert M; Pfeffer Marc A; White Harvey D;
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry.
European heart journal 2005;26(20):2114-9.
2005: Eisenstein Eric L; McGuire Darren K; Bhapkar Manjushri V; Kristinsson Arni; Hochman Judith S; Kong David F; Califf Robert M; Van de Werf Frans; Yancy William S; Newby L Kristin
Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes.
The American journal of medicine 2005;118(9):981-90.
2005: Califf Robert M
Stenting or surgery: an opportunity to do it right.
Journal of the American College of Cardiology 2005;46(4):589-91.
2005: Reed Shelby D; Radeva Jasmina I; Weinfurt Kevin P; McMurray John J V; Pfeffer Marc A; Velazquez Eric J; Allsbrook Jennifer S; Masselink Leah E; Sellers Mary Ann; Califf Robert M; Schulman Kevin A;
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
American heart journal 2005;150(2):323-9.
2005: Ohman E Magnus; Van de Werf Frans; Antman Elliott M; Califf Robert M; de Lemos James A; Gibson C Michael; Oliverio Renee L; Harrelson Lynn; McCabe Carolyn; DiBattiste Peter; Braunwald Eugene;
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial.
American heart journal 2005;150(1):79-88.
2005: Jiang Wei; Glassman Alexander; Krishnan Ranga; O'Connor Christopher M; Califf Robert M
Depression and ischemic heart disease: what have we learned so far and what must we do in the future?
American heart journal 2005;150(1):54-78.
2005: Wong Cheuk-Kit; French John K; Aylward Philip E G; Stewart Ralph A H; Gao Wanzhen; Armstrong Paul W; Van De Werf Frans J J; Simes R John; Raffel O Christopher; Granger Christopher B; Califf Robert M; White Harvey D;
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
Journal of the American College of Cardiology 2005;46(1):29-38.
2005: Reddan Donal N; Szczech Lynda Anne; Hasselblad Vic; Lowrie Edmund G; Lindsay Robert M; Himmelfarb Jonathan; Toto Robert D; Stivelman John; Winchester James F; Zillman Linda A; Califf Robert M; Owen William F
Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial.
Journal of the American Society of Nephrology : JASN 2005;16(7):2162-9.
2005: Al-Khatib Sana M; Sanders Gillian D; Mark Daniel B; Lee Kerry L; Bardy Gust H; Bigger J Thomas; Buxton Alfred E; Connolly Stuart; Kadish Alan; Moss Arthur; Feldman Arthur M; Ellenbogen Kenneth A; Singh Steven; Califf Robert M;
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
American heart journal 2005;149(6):1020-34.
2005: Giugliano Robert P; Newby L Kristin; Harrington Robert A; Gibson C Michael; Van de Werf Frans; Armstrong Paul; Montalescot Gilles; Gilbert James; Strony John T; Califf Robert M; Braunwald Eugene;
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale.
American heart journal 2005;149(6):994-1002.
2005: Solomon Scott D; Zelenkofske Steve; McMurray John J V; Finn Peter V; Velazquez Eric; Ertl George; Harsanyi Adam; Rouleau Jean L; Maggioni Aldo; Kober Lars; White Harvey; Van de Werf Frans; Pieper Karen; Califf Robert M; Pfeffer Marc A;
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
The New England journal of medicine 2005;352(25):2581-8.
2005: Solomon Scott D; Skali Hicham; Anavekar Nagesh S; Bourgoun Mikhail; Barvik Stale; Ghali Jalal K; Warnica J Wayne; Khrakovskaya Margarita; Arnold J Malcolm O; Schwartz Yuri; Velazquez Eric J; Califf Robert M; McMurray John V; Pfeffer Marc A
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Circulation 2005;111(25):3411-9.
2005: Mehta Rajendra H; Califf Robert M; Garg Jyotsna; Pieper Karen S; Alexander John H; Moliterno David J; Van de Werf Frans; Ohman E Magnus; White Harvey D; Topol Eric J; Granger Christopher B
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy.
The American journal of cardiology 2005;95(11):1371-5.
2005: Al-Khatib Sana M; Allen LaPointe Nancy M; Kramer Judith M; Chen Anita Y; Hammill Bradley G; Delong Liz; Califf Robert M
A survey of health care practitioners' knowledge of the QT interval.
Journal of general internal medicine 2005;20(5):392-6.
2005: Klein Liviu; O'Connor Christopher M; Leimberger Jeffrey D; Gattis-Stough Wendy; Piña Ileana L; Felker G Michael; Adams Kirkwood F; Califf Robert M; Gheorghiade Mihai;
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Circulation 2005;111(19):2454-60.
2005: Cohen Mauricio G; Kelly Robert V; Kong David F; Menon Venu; Shah Monica; Ferreira Jorge; Pieper Karen S; Criger Douglas; Poggio Rosana; Ohman E Magnus; Gore Joel; Califf Robert M; Granger Christopher B
Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials.
The American journal of medicine 2005;118(5):482-8.
2005: March John S; Silva Susan G; Compton Scott; Shapiro Mark; Califf Robert; Krishnan Ranga
The case for practical clinical trials in psychiatry.
The American journal of psychiatry 2005;162(5):836-46.
2005: Califf Robert M; Petersen John L; Hasselblad Vic; Mahaffey Kenneth W; Ferguson James J
A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.
American heart journal 2005;149(4 Suppl):S91-9.
2005: Meine Trip J; Al-Khatib Sana M; Alexander John H; Granger Christopher B; White Harvey D; Kilaru Rakhi; Williams Kathryn; Ohman E Magnus; Topol Eric; Califf Robert M
Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy.
American heart journal 2005;149(4):670-4.
2005: Al-Khatib Sana M; Anstrom Kevin J; Eisenstein Eric L; Peterson Eric D; Jollis James G; Mark Daniel B; Li Yun; O'Connor Christopher M; Shaw Linda K; Califf Robert M
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.
Annals of internal medicine 2005;142(8):593-600.
2005: Mehta Rajendra H; Alexander John H; Van de Werf Frans; Armstrong Paul W; Pieper Karen S; Garg Jyotsna; Califf Robert M; Granger Christopher B
Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes.
JAMA : the journal of the American Medical Association 2005;293(14):1746-50.
2005: Eisenstein Eric L; Lemons Philip W; Tardiff Barbara E; Schulman Kevin A; Jolly M King; Califf Robert M
Reducing the costs of phase III cardiovascular clinical trials.
American heart journal 2005;149(3):482-8.
2005: Reed Shelby D; Anstrom Kevin J; Bakhai Ameet; Briggs Andrew H; Califf Robert M; Cohen David J; Drummond Michael F; Glick Henry A; Gnanasakthy Ari; Hlatky Mark A; O'Brien Bernie J; Torti Frank M; Tsiatis Anastasios A; Willan Andrew R; Mark Daniel B; Schulman Kevin A
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.
American heart journal 2005;149(3):434-43.
2005: Muni Neal I; Califf Robert M; Foy Jonette R; Boam Ashley B; Zuckerman Bram D; Kuntz Richard E
Coronary drug-eluting stent development: issues in trial design.
American heart journal 2005;149(3):415-33.
2005: Drew Barbara J; Califf Robert M; Funk Marjorie; Kaufman Elizabeth S; Krucoff Mitchell W; Laks Michael M; Macfarlane Peter W; Sommargren Claire; Swiryn Steven; Van Hare George F;
AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized electrocardiology and the American Association of Critical-Care Nurses.
The Journal of cardiovascular nursing 2005;20(2):76-106.
2005: Kupersmith Joel; Sung Nancy; Genel Myron; Slavkin Harold; Califf Robert; Bonow Robert; Sherwood Louis; Reame Nancy; Catanese Veronica; Baase Catherine; Feussner John; Dobs Adrian; Tilson Hugh; Reece E Albert
Creating a new structure for research on health care effectiveness.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2005;53(2):67-72.
2005: Rebeiz Abdallah G; Johanson Per; Green Cindy L; Crater Suzanne W; Roe Matthew T; Langer Anatoly; Giugliano Robert P; Lincoff A Michael; Newby L Kristin; Harrington Robert A; Topol Eric J; Califf Robert M; Wagner Galen S; Krucoff Mitchell W
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).
The American journal of cardiology 2005;95(5):611-4.
2005: Califf Robert M
Simple principles of clinical trials remain powerful.
JAMA : the journal of the American Medical Association 2005;293(4):489-91.
2005: Miranda Phillippa J; DeFronzo Ralph A; Califf Robert M; Guyton John R
Metabolic syndrome: definition, pathophysiology, and mechanisms.
American heart journal 2005;149(1):33-45.
2005: Miranda Phillippa J; DeFronzo Ralph A; Califf Robert M; Guyton John R
Metabolic syndrome: evaluation of pathological and therapeutic outcomes.
American heart journal 2005;149(1):20-32.
2005: Borges-Neto Salvador; Shaw Linda K; Tuttle Robert H; Alexander John H; Smith William T; Chambless Marianna; Coleman R Edward; Harrington Robert A; Califf Robert M
Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease.
The American journal of cardiology 2005;95(2):182-8.
2005: Labinaz Marino; Mathias Jasmine; Pieper Karen; Granger Christopher B; Lincoff A Michael; Moliterno David J; Van de Werf Frans; Simes John; White Harvey D; Simoons Maarten L; Califf Robert M; Topol Eric J; Armstrong Paul W; Harrington Robert A
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
European heart journal 2005;26(2):128-36.
2004: Mascelli Mary Ann; Deliargyris Efthymios N; Damaraju Lakshmi V; Barnathan Elliot S; Califf Robert M; Simoons Maarten L; Sane David C
Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromes.
Journal of thrombosis and thrombolysis 2004;18(3):171-5.
2004: Felker G Michael; Leimberger Jeffrey D; Califf Robert M; Cuffe Michael S; Massie Barry M; Adams Kirkwood F; Gheorghiade Mihai; O'Connor Christopher M
Risk stratification after hospitalization for decompensated heart failure.
Journal of cardiac failure 2004;10(6):460-6.
2004: Armstrong Paul W; Newby L Kristin; Granger Christopher B; Lee Kerry L; Simes R John; Van de Werf Frans; White Harvey D; Califf Robert M;
Lessons learned from a clinical trial.
Circulation 2004;110(23):3610-4.
2004: Madan Mina; Labinaz Marino; Cohen Eric A; Buller Christopher E; Cantor Warren J; Seidelin Peter; Ducas John; Carere Ronald G; Natarajan Madhu K; Pieper Karen S; Hafley Gail E; O'Shea J Conor; Kitt Michael M; Califf Robert M; Tcheng James E;
A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting.
The Canadian journal of cardiology 2004;20(13):1343-9.
2004: Jiang Wei; Kuchibhatla Maragatha; Cuffe Michael S; Christopher Eric J; Alexander Jude D; Clary Greg L; Blazing Michael A; Gaulden Laura H; Califf Robert M; Krishnan Ranga R; O'Connor Christopher M
Prognostic value of anxiety and depression in patients with chronic heart failure.
Circulation 2004;110(22):3452-6.
2004: Califf Robert M; Ryan Thomas; Douglas Pamela; Goldschmidt-Clermont Pascal J
A time of accelerated change in academic cardiovascular medicine: implications for academic divisions of cardiology and their training programs.
Journal of the American College of Cardiology 2004;44(10):1957-65.
2004: Barbagelata Alejandro; Califf Robert M; Sgarbossa Elena B; Knight David; Mark Daniel B; Granger Christopher B; Armstrong Paul W; Elizari Marcelo; Birnbaum Yochai; Grinfeld Liliana R; Ohman E Magnus; Wagner Galen S;
Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.
American heart journal 2004;148(5):795-802.
2004: Velazquez Eric J; Francis Gary S; Armstrong Paul W; Aylward Phillip E; Diaz Rafael; O'Connor Christopher M; White Harvey D; Henis Marc; Rittenhouse Lois M; Kilaru Rakhi; van Gilst Wiek; Ertl Georg; Maggioni Aldo P; Spac Jiri; Weaver W Douglas; Rouleau Jean-Lucien; McMurray John J V; Pfeffer Marc A; Califf Robert M;
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Califf Robert M; Smith Sidney C
Introduction. Quality of health care.
American heart journal 2004;148(5 Suppl):S27-8.
2004: Parsons Elizabeth; Newby L Kristin; Bhapkar Manjushri V; Alexander Karen P; White Harvey D; Shah Svati H; Bushnell Cheryl D; Califf Robert M;
Postmenopausal hormone use in women with acute coronary syndromes.
Journal of women's health (2002) 2004;13(8):863-71.
2004: Drew Barbara J; Califf Robert M; Funk Marjorie; Kaufman Elizabeth S; Krucoff Mitchell W; Laks Michael M; Macfarlane Peter W; Sommargren Claire; Swiryn Steven; Van Hare George F;
Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses.
Circulation 2004;110(17):2721-46.
2004: Califf Robert M; Nissen Steven E; DeMaria Anthony N; Ohman Erik Magnus; Pitt Bertram; Willerson James T; Bilheimer David W; Cohn Jay N; Feigal David W; Hampson Lindsay; Lorell Beverly H; Pepine Carl J; Popp Richard L
Task force 2: Investigator participation in clinical research.
Journal of the American College of Cardiology 2004;44(8):1729-36.
2004: Rao Sunil V; Jollis James G; Harrington Robert A; Granger Christopher B; Newby L Kristin; Armstrong Paul W; Moliterno David J; Lindblad Lauren; Pieper Karen; Topol Eric J; Stamler Jonathan S; Califf Robert M
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2004;292(13):1555-62.
2004: de Lemos James A; Blazing Michael A; Wiviott Stephen D; Brady William E; White Harvey D; Fox Keith A A; Palmisano Joanne; Ramsey Karen E; Bilheimer David W; Lewis Eldrin F; Pfeffer M; Califf Robert M; Braunwald Eugene;
Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
European heart journal 2004;25(19):1688-94.
2004: Kassem-Moussa Hassan; Mahaffey Kenneth W; Graffagnino Carmelo; Tasissa Gudaye; Sila Cathy A; Simes R John; White Harvey D; Califf Robert M; Bhapkar Manjshri V; Newby L Kristin;
Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
American heart journal 2004;148(3):439-46.
2004: Anavekar Nagesh S; McMurray John J V; Velazquez Eric J; Solomon Scott D; Kober Lars; Rouleau Jean-Lucien; White Harvey D; Nordlander Rolf; Maggioni Aldo; Dickstein Kenneth; Zelenkofske Steven; Leimberger Jeffrey D; Califf Robert M; Pfeffer Marc A
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
The New England journal of medicine 2004;351(13):1285-95.
2004: Kaul Padma; Armstrong Paul W; Chang Wei-Ching; Naylor C David; Granger Christopher B; Lee Kerry L; Peterson Eric D; Califf Robert M; Topol Eric J; Mark Daniel B
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
Circulation 2004;110(13):1754-60.
2004: Al-Khatib Sana M; Shaw Linda K; Lee Kerry L; O'Connor Christopher; Califf Robert M
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?
The American journal of cardiology 2004;94(6):797-800.
2004: Aguilar David; Solomon Scott D; Køber Lars; Rouleau Jean-Lucien; Skali Hicham; McMurray John J V; Francis Gary S; Henis Marc; O'Connor Christopher M; Diaz Rafael; Belenkov Yuri N; Varshavsky Sergei; Leimberger Jeffrey D; Velazquez Eric J; Califf Robert M; Pfeffer Marc A
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Circulation 2004;110(12):1572-8.
2004: de Lemos James A; Blazing Michael A; Wiviott Stephen D; Lewis Eldrin F; Fox Keith A A; White Harvey D; Rouleau Jean-Lucien; Pedersen Terje R; Gardner Laura H; Mukherjee Robin; Ramsey Karen E; Palmisano Joanne; Bilheimer David W; Pfeffer Marc A; Califf Robert M; Braunwald Eugene;
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
JAMA : the journal of the American Medical Association 2004;292(11):1307-16.
2004: Li Jennifer S; Berezny Katherine; Kilaru Rakhi; Hazan Lydie; Portman Ronald; Hogg Ronald; Jenkins Randall D; Kanani Prapti; Cottrill Carol M; Mattoo Tej K; Zharkova Ludmila; Kozlova Ludmila; Weisman Irit; Deitchman David; Califf Robert M
Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?
Hypertension 2004;44(3):289-93.
2004: Petersen John L; Mahaffey Kenneth W; Becker Richard C; Goodman Shaun G; Kleiman Neal S; Marian A J; Stone Gregg W; Lansky Alexandra J; Lincoff A Michael; Hazen Stanley L; Nessel Christopher C; Toro-Figueroa Luis; Tate Lynn; Reist Craig J; Cohen Marc; Califf Robert M; Ferguson James J;
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library.
American heart journal 2004;148(2):269-76.
2004: McCullough Peter A; Bakris George L; Owen William F; Klassen Preston S; Califf Robert M
Slowing the progression of diabetic nephropathy and its cardiovascular consequences.
American heart journal 2004;148(2):243-51.
2004: Best Patricia J M; Reddan Donal N; Berger Peter B; Szczech Lynda A; McCullough Peter A; Califf Robert M
Cardiovascular disease and chronic kidney disease: insights and an update.
American heart journal 2004;148(2):230-42.
2004: Gibson C Michael; Jennings Lisa K; Murphy Sabina A; Lorenz David P; Giugliano Robert P; Harrington Robert A; Cholera Shila; Krishnan Rajini; Califf Robert M; Braunwald Eugene;
Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy.
Circulation 2004;110(6):679-84.
2004: Baughman Kenneth Lee; Pepine Carl J; Abrams Jonathan; Bashore Thomas M; Califf Robert M; Feldman Arthur M; Fye W Bruce; Griffin Brian P; Myerburg Robert J; Naccarelli Gerald V; Williams Eric S
Working group 1: How to increase the output of cardiologists.
Journal of the American College of Cardiology 2004;44(2):233-7.
2004: Petersen John L; Mahaffey Kenneth W; Hasselblad Vic; Antman Elliott M; Cohen Marc; Goodman Shaun G; Langer Anatoly; Blazing Michael A; Le-Moigne-Amrani Anne; de Lemos James A; Nessel Christopher C; Harrington Robert A; Ferguson James J; Braunwald Eugene; Califf Robert M
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
JAMA : the journal of the American Medical Association 2004;292(1):89-96.
2004: Blazing Michael A; de Lemos James A; White Harvey D; Fox Keith A A; Verheugt Freek W A; Ardissino Diego; DiBattiste Peter M; Palmisano Joanne; Bilheimer David W; Snapinn Steven M; Ramsey Karen E; Gardner Laura H; Hasselblad Vic; Pfeffer Marc A; Lewis Eldrin F; Braunwald Eugene; Califf Robert M;
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(1):55-64.
2004: Ferguson James J; Califf Robert M; Antman Elliott M; Cohen Marc; Grines Cindy L; Goodman Shaun; Kereiakes Dean J; Langer Anatoly; Mahaffey Kenneth W; Nessel Christopher C; Armstrong Paul W; Avezum Alvaro; Aylward Phil; Becker Richard C; Biasucci Luigi; Borzak Steven; Col Jacques; Frey Marty J; Fry Ed; Gulba Dietrich C; Guneri Sema; Gurfinkel Enrique; Harrington Robert; Hochman Judith S; Kleiman Neal S; Leon Martin B; Lopez-Sendon Jose Luis; Pepine Carl J; Ruzyllo Witold; Steinhubl Steven R; Teirstein Paul S; Toro-Figueroa Luis; White Harvey;
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
JAMA : the journal of the American Medical Association 2004;292(1):45-54.
2004: Reed Shelby D; Friedman Joëlle Y; Velazquez Eric J; Gnanasakthy Ari; Califf Robert M; Schulman Kevin A
Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
American heart journal 2004;148(1):122-8.
2004: Chang Wei-Ching; Boersma Eric; Granger Christopher B; Harrington Robert A; Califf Robert M; Simoons Maarten L; Kleiman Neal S; Armstrong Paul W;
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT.
American heart journal 2004;148(1):62-71.
2004: Labinaz Marino; Kaul Padma; Harrington Robert A; Chang Wei-Ching; Kleiman Neal S; Simoons Maarten L; Boersma Eric; Akkerhuis K Martijn; Califf Robert M; Armstrong Paul W;
Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial.
The Canadian journal of cardiology 2004;20(8):773-8.
2004: Peterson Eric D; Hirshfeld John W; Ferguson T Bruce; Kramer Judith M; Califf Robert M; Kessler Larry G
Part II: Sealing holes in the safety net.
American heart journal 2004;147(6):985-90.
2004: O'Shea J Conor; Kramer Judith M; Califf Robert M; Peterson Eric D
Part I: Identifying holes in the safety net.
American heart journal 2004;147(6):977-84.
2004: Waters Richard E; Singh Kanwar P; Roe Matthew T; Lotfi Mat; Sketch Michael H; Mahaffey Kenneth W; Newby L Kristin; Alexander John H; Harrington Robert A; Califf Robert M; Granger Christopher B
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;43(12):2153-9.
2004: Califf Robert M
Benefit the patient, manage the risk: a system goal.
Pharmacoepidemiology and drug safety 2004;13(5):269-76.
2004: March John S; Silva Susan G; Compton Scott; Anthony Ginger; DeVeaugh-Geiss Joseph; Califf Robert; Krishnan Ranga
The Child and Adolescent Psychiatry Trials Network (CAPTN).
Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(5):515-8.
2004: Califf Robert M
Watching the WATCH trial: the role of sponsors and data monitoring committees.
Journal of cardiac failure 2004;10(2):113-4.
2004: Maas Arthur C P; Wyatt Christina M; Green Cynthia L; Wagner Galen S; Trollinger Kathleen M; Pope James E; Langer Anatoly; Armstrong Paul W; Califf Robert M; Simoons Maarten L; Krucoff Mitchell W
Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.
American heart journal 2004;147(4):698-704.
2004: Califf Robert M; Fowler Vance; Cabell Christopher H; Corey G Ralph
Novel approaches to clinical trials: device-related infections.
American heart journal 2004;147(4):599-604.
2004: Gibson C Michael; Karha Juhana; Murphy Sabina A; de Lemos James A; Morrow David A; Giugliano Robert P; Roe Mathew T; Harrington Robert A; Cannon Christopher P; Antman Elliott M; Califf Robert M; Braunwald Eugene;
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.
Journal of the American College of Cardiology 2004;43(7):1170-6.
2004: Quinn Martin J; Aronow Herbert D; Califf Robert M; Bhatt Deepak L; Sapp Shelly; Kleiman Neal S; Harrington Robert A; Kong David F; Kandzari David E; Topol Eric J
Aspirin dose and six-month outcome after an acute coronary syndrome.
Journal of the American College of Cardiology 2004;43(6):972-8.
2004: Bittl John A; Chew Derek P; Topol Eric J; Kong David F; Califf Robert M
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty.
Journal of the American College of Cardiology 2004;43(6):936-42.
2004: Berger Peter B; Sketch Michael H; Califf Robert M
Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)?
Circulation 2004;109(9):1079-81.
2004: Kandzari David E; Hasselblad Vic; Tcheng James E; Stone Gregg W; Califf Robert M; Kastrati Adnan; Neumann Franz-Josef; Brener Sorin J; Montalescot Gilles; Kong David F; Harrington Robert A
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.
American heart journal 2004;147(3):457-62.
2004: Kong David F; Eisenstein Eric L; Sketch Michael H; Zidar James P; Ryan Thomas J; Harrington Robert A; Newman Mark F; Smith Peter K; Mark Daniel B; Califf Robert M
Economic impact of drug-eluting stents on hospital systems: a disease-state model.
American heart journal 2004;147(3):449-56.
2004: Kandzari David E; Chu Alan; Brodie Bruce R; Stuckey Thomas A; Hermiller James B; Vetrovec George W; Hannan Karen L; Krucoff Mitchell W; Christenson Robert H; Gibbons Raymond J; Sigmon Kristina N; Garg Jyostna; Hasselblad Victor; Collins Kenneth; Harrington Robert A; Berger Peter B; Chronos Nicholas A; Hochman Judith S; Califf Robert M
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).
The American journal of cardiology 2004;93(5):636-9.
2004: Roe M T; Mahaffey K W; Kilaru R; Alexander J H; Akkerhuis K M; Simoons M L; Harrington R A; Tardiff B E; Granger C B; Ohman E M; Moliterno D J; Lincoff A M; Armstrong P W; Van de Werf F; Califf R M; Topol E J
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
European heart journal 2004;25(4):313-21.
2004: Kaul Padma; Newby L Kristin; Fu Yuling; Mark Daniel B; Califf Robert M; Topol Eric J; Aylward Phil; Granger Christopher B; Van de Werf Frans; Armstrong Paul W
International differences in evolution of early discharge after acute myocardial infarction.
Lancet 2004;363(9408):511-7.
2004: James Stefan K; Lindahl Bertil; Armstrong Paul; Califf Robert; Simoons M L Maarten L; Venge Per; Wallentin Lars;
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.
International journal of cardiology 2004;93(2-3):113-20.
2004: Gurm Hitinder S; Lincoff A Michael; Lee David; Tang W H Wilson; Jia Gang; Booth Joan E; Califf Robert M; Ohman E M; Van de Werf Frans; Armstrong Paul W; Guetta Victor; Wilcox Robert; Topol Eric J;
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
Journal of the American College of Cardiology 2004;43(4):542-8.
2004: Nabel Elizabeth G; Selker Harry P; Califf Robert M; Canto John G; Cao Jie J; Desvigne-Nikkens Patrice; Goldberg Robert J; Finnegan John R; Vaccarino Viola; Virmani Renu;
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 3: diagnosis and treatment of acute cardiac ischemia: gender issues.
Circulation 2004;109(6):e50-2.
2004: Kandzari David E; Granger Christopher B; Simoons Maarten L; White Harvey D; Simes John; Mahaffey Kenneth W; Gore Joel; Weaver W Douglas; Longstreth William T; Stebbins Amanda; Lee Kerry L; Califf Robert M; Topol Eric J;
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
The American journal of cardiology 2004;93(4):458-61.
2004: Pieper Karen S; Tsiatis Anastasios A; Davidian Marie; Hasselblad Vic; Kleiman Neal S; Boersma Eric; Chang Wei-Ching; Griffin Jeffrey; Armstrong Paul W; Califf Robert M; Harrington Robert A
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.
Circulation 2004;109(5):641-6.
2004: James Stefan K; Siegbahn Agneta; Armstrong Paul; Barnathan Elliott; Califf Robert; Simoons Maarten L; Wallentin Lars
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.
American heart journal 2004;147(2):267-74.
2004: McGuire Darren K; Newby L Kristin; Bhapkar Manjushri V; Moliterno David J; Hochman Judith S; Klein Werner W; Weaver W Douglas; Pfisterer Matthias; Corbalán Ramón; Dellborg Mikael; Granger Christopher B; Van De Werf Frans; Topol Eric J; Califf Robert M;
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
American heart journal 2004;147(2):246-52.
2004: Califf Robert M
Defining the balance of risk and benefit in the era of genomics and proteomics.
Health affairs (Project Hope) 2004;23(1):77-87.
2004: Rebeiz Abdallah G; Roe Matthew T; Alexander John H; Mahaffey Kenneth W; Granger Christopher B; Peterson Eric D; Califf Robert M; Harrington Robert A
Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes.
The American journal of medicine 2004;116(2):119-29.
2004: Cowper Patricia A; DeLong Elizabeth R; Whellan David J; Allen LaPointe Nancy M; Califf Robert M
Economic effects of beta-blocker therapy in patients with heart failure.
The American journal of medicine 2004;116(2):104-11.
2004: DeMets David; Califf Robert; Dixon Dennis; Ellenberg Susan; Fleming Thomas; Held Peter; Julian Desmond; Kaplan Richard; Levine Robert; Neaton James; Packer Milton; Pocock Stuart; Rockhold Frank; Seto Belinda; Siegel Jay; Snapinn Steve; Stump David; Temple Robert; Whitley Richard
Issues in regulatory guidelines for data monitoring committees.
Clinical trials (London, England) 2004;1(2):162-9.
2004: DeMets David L; Fleming Thomas R; Rockhold Frank; Massie Barry; Merchant Thomas; Meisel Alan; Mishkin Barbara; Wittes Janet; Stump David; Califf Robert
Liability issues for data monitoring committee members.
Clinical trials (London, England) 2004;1(6):525-31.
2003: Newby L Kristin; Bhapkar Manjushri V; White Harvey D; Moliterno David J; LaPointe Nancy M Allen; Kandzari David E; Verheugt Freek W A; Kramer Judith M; Armstrong Paul W; Califf Robert M;
Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.
Journal of thrombosis and thrombolysis 2003;16(3):119-28.
2003: Stamler Jonathan S; Taber Robert L; Califf Robert M
Translation of academic discovery into societal benefit: proposal for a balanced approach--part 2.
The American journal of medicine 2003;115(8):683-8.
2003: Alexander John H; Harrington Robert A; Bhapkar Manju; Mahaffey Kenneth W; Lincoff A Michael; Ohman E Magnus; Klootwijk Peter; Pahlm Olle; Henden Bo; Deckers Jaap W; Simoons Maarten L; Califf Robert M; Wagner Galen S
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes.
The American journal of medicine 2003;115(8):613-9.
2003: Kramer Judith M; Newby L Kristin; Chang Wei Ching; Simes R John; Van de Werf Frans; Granger Christopher B; Lee Kerry L; White Harvey D; Piegas Leopoldo S; Topol Eric J; Califf Robert M; Armstrong Paul W;
International variation in the use of evidence-based medicines for acute coronary syndromes.
European heart journal 2003;24(23):2133-41.
2003: Pfeffer Marc A; McMurray John J V; Velazquez Eric J; Rouleau Jean-Lucien; Køber Lars; Maggioni Aldo P; Solomon Scott D; Swedberg Karl; Van de Werf Frans; White Harvey; Leimberger Jeffrey D; Henis Marc; Edwards Susan; Zelenkofske Steven; Sellers Mary Ann; Califf Robert M;
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
The New England journal of medicine 2003;349(20):1893-906.
2003: Mahaffey Kenneth W; Lewis Bruce E; Wildermann Nancy M; Berkowitz Scott D; Oliverio Renee M; Turco Mark A; Shalev Yoseph; Ver Lee Peter; Traverse Jay H; Rodriguez A Ralph; Ohman E Magnus Ohman; Harrington Robert A; Califf Robert M;
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
The Journal of invasive cardiology 2003;15(11):611-6.
2003: Stamler Jonathan S; Taber Robert L; Califf Robert M
Translation of academic discovery into societal benefit: proposal for a balanced approach--part 1.
The American journal of medicine 2003;115(7):596-9.
2003: Allen LaPointe Nancy M; Chen Anita; Hammill Bradley; DeLong Elizabeth; Kramer Judith M; Califf Robert M
Evaluation of the dofetilide risk-management program.
American heart journal 2003;146(5):894-901.
2003: Califf R M
Issues facing clinical trials of the future.
Journal of internal medicine 2003;254(5):426-33.
2003: Califf Robert M
Supplement on acute coronary syndromes: introduction.
Circulation 2003;108(16 Suppl 1):III1-5.
2003: Roe Matthew T; Ohman E Magnus; Pollack Charles V; Peterson Eric D; Brindis Ralph G; Harrington Robert A; Christenson Robert H; Smith Sidney C; Califf Robert M; Gibler W Brian
Changing the model of care for patients with acute coronary syndromes.
American heart journal 2003;146(4):605-12.
2003: Savonitto S; Armstrong P W; Lincoff A M; Jia G; Sila C A; Booth J; Terrosu P; Cavallini C; White H D; Ardissino D; Califf R M; Topol E J
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial.
European heart journal 2003;24(20):1807-14.
2003: Wong Cheuk-Kit; White Harvey D; Wilcox Robert G; Criger Douglas A; Califf Robert M; Topol Eric J; Ohman E Magnus
Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
Cardiac electrophysiology review 2003;7(3):201-7.
2003: Kong David F; Hasselblad Vic; Harrington Robert A; White Harvey D; Tcheng James E; Kandzari David E; Topol Eric J; Califf Robert M
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.
The American journal of cardiology 2003;92(6):651-5.
2003: Reddan Donal N; Szczech Lynda Anne; Tuttle Robert H; Shaw Linda K; Jones Robert H; Schwab Steve J; Smith Mark Stafford; Califf Robert M; Mark Daniel B; Owen William F
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.
Journal of the American Society of Nephrology : JASN 2003;14(9):2373-80.
2003: Califf Robert M; Muhlbaier Lawrence H
Health Insurance Portability and Accountability Act (HIPAA): must there be a trade-off between privacy and quality of health care, or can we advance both?
Circulation 2003;108(8):915-8.
2003: James Stefan; Armstrong Paul; Califf Robert; Simoons Maarten L; Venge Per; Wallentin Lars; Lindahl Bertil
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.
The American journal of medicine 2003;115(3):178-84.
2003: Velazquez Eric J; Pfeffer Marc A; McMurray John V; Maggioni Aldo P; Rouleau Jean Lucien; Van de Werf Frans; Kober Lars; White Harvey D; Swedberg Karl; Leimberger Jeffrey D; Gallo Paul; Sellers Mary Ann; Edwards Susan; Henis Marc; Califf Robert M;
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(4):537-44.
2003: Serebruany Victor L; Glassman Alexander H; Malinin Alex I; Nemeroff Charles B; Musselman Dominique L; van Zyl Louis T; Finkel Mitchell S; Krishnan K Ranga R; Gaffney Michael; Harrison Wilma; Califf Robert M; O'Connor Christopher M;
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
Circulation 2003;108(8):939-44.
2003: Tolleson Thaddeus R; Newby L Kristin; Harrington Robert A; Bhapkar Manjushri V; Verheugt Freek W A; Berger Peter B; Moliterno David J; White Harvey D; Ohman E Magnus; Van de Werf Frans; Topol Eric J; Califf Robert M;
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
The American journal of cardiology 2003;92(3):330-3.
2003: Topol Eric J; Easton Donald; Harrington Robert A; Amarenco Pierre; Califf Robert M; Graffagnino Carmen; Davis Stephen; Diener Hans-Christophe; Ferguson James; Fitzgerald Desmond; Granett Jeffrey; Shuaib Ashfaq; Koudstaal Peter J; Theroux Pierre; Van de Werf Frans; Sigmon Kristina; Pieper Karen; Vallee Marc; Willerson James T;
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
Circulation 2003;108(4):399-406.
2003: James Stefan K; Lindahl Bertil; Siegbahn Agneta; Stridsberg Mats; Venge Per; Armstrong Paul; Barnathan Elliot S; Califf Robert; Topol Eric J; Simoons Maarten L; Wallentin Lars
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
Circulation 2003;108(3):275-81.
2003: Califf Robert M; Morse Michael A; Wittes Janet; Goodman Steven N; Nelson Daniel K; DeMets David L; Iafrate R Peter; Sugarman Jeremy
Toward protecting the safety of participants in clinical trials.
Controlled clinical trials 2003;24(3):256-71.
2003: Williams R Taylor; Damaraju Lakshmi V; Mascelli Mary Ann; Barnathan Elliot S; Califf Robert M; Simoons Maarten L; Deliargyris Efthymios N; Sane David C
Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.
Circulation 2003;107(18):2307-12.
2003: LaPointe Nancy M Allen; Al-Khatib Sana M; Kramer Judith M; Califf Robert M
Knowledge deficits related to the QT interval could affect patient safety.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2003;8(2):157-60.
2003: Tcheng James E; Madan Mina; O'Shea J Conor; Cohen Eric A; Buller Christopher E; Lincoff A Michael; Popma Jeffrey J; Teirstein Paul S; Kitt Michael M; Lorenz Todd J; Greenberg Sally; Fost Norman; Califf Robert M
Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.
Journal of interventional cardiology 2003;16(2):97-105.
2003: Campbell William H; Califf Robert M
Improving communication of drug risks to prevent patient injury: proceedings of a workshop.
Pharmacoepidemiology and drug safety 2003;12(3):183-94.
2003: Belch Jill J F; Topol Eric J; Agnelli Giancarlo; Bertrand Michel; Califf Robert M; Clement Denis L; Creager Mark A; Easton J Donald; Gavin James R; Greenland Philip; Hankey Graeme; Hanrath Peter; Hirsch Alan T; Meyer Jürgen; Smith Sidney C; Sullivan Frank; Weber Michael A;
Critical issues in peripheral arterial disease detection and management: a call to action.
Archives of internal medicine 2003;163(8):884-92.
2003: Al-Khatib Sana M; LaPointe Nancy M Allen; Kramer Judith M; Califf Robert M
What clinicians should know about the QT interval.
JAMA : the journal of the American Medical Association 2003;289(16):2120-7.
2003: Giugliano Robert P; Roe Matthew T; Harrington Robert A; Gibson C Michael; Zeymer Uwe; Van de Werf Frans; Baran Kenneth W; Hobbach Hans Peter; Woodlief Lynn H; Hannan Karen L; Greenberg Sally; Miller Joanne; Kitt Michael M; Strony John; McCabe Carolyn H; Braunwald Eugene; Califf Robert M;
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
Journal of the American College of Cardiology 2003;41(8):1251-60.
2003: Reddan Donal; Szczech Lynda A; O'Shea Susan; Califf Robert M
Anticoagulation in acute cardiac care in patients with chronic kidney disease.
American heart journal 2003;145(4):586-94.
2003: Rao Sunil V; Califf Robert M
Lessons learned from clinical trials: a roundtable discussion.
Critical pathways in cardiology 2003;2(1):55-9.
2003: Khadour Fadi H; Fu Yuling; Chang Wei-Ching; Ma Xin; Mark Dan; Granger Christopher B; Topol Eric J; Califf Robert M; Armstrong Paul W;
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes.
The Canadian journal of cardiology 2003;19(3):257-63.
2003: Al-Khatib Sana M; Stebbins Amanda L; Califf Robert M; Lee Kerry L; Granger Christopher B; White Harvey D; Armstrong Paul W; Topol Eric J; Ohman E Magnus;
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
American heart journal 2003;145(3):515-21.
2003: Califf Robert M; Faxon David P
Need for centers to care for patients with acute coronary syndromes.
Circulation 2003;107(11):1467-70.
2003: Felker G Michael; Benza Raymond L; Chandler A Bleakley; Leimberger Jeffrey D; Cuffe Michael S; Califf Robert M; Gheorghiade Mihai; O'Connor Christopher M;
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
Journal of the American College of Cardiology 2003;41(6):997-1003.
2003: James Stefan K; Armstrong Paul; Barnathan Elliott; Califf Robert; Lindahl Bertil; Siegbahn Agneta; Simoons Maarten L; Topol Eric J; Venge Per; Wallentin Lars;
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2003;41(6):916-24.
2003: Hersi A; Fu Y; Wong B; Mahaffey K W; Harrington R A; Califf R M; Van de Werf F; Armstrong P W;
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?
European heart journal 2003;24(6):522-31.
2003: Batchelor Wayne B; Mark Daniel B; Knight J David; Granger Christopher B; Armstrong Paul W; Califf Robert M; Peterson Eric D
Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada.
American heart journal 2003;145(2):349-55.
2003: Curtis Lesley H; Østbye Truls; Sendersky Veronica; Hutchison Steve; Allen LaPointe Nancy M; Al-Khatib Sana M; Usdin Yasuda Sally; Dans Peter E; Wright Alan; Califf Robert M; Woosley Raymond L; Schulman Kevin A
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
The American journal of medicine 2003;114(2):135-41.
2003: Cho Leslie; Bhatt Deepak L; Marso Steve P; Brennan Danielle; Holmes David R; Califf Robert M; Topol Eric J
An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial.
The American journal of medicine 2003;114(2):106-11.
2003: Kaul Padma; Newby L Kristin; Fu Yuling; Hasselblad Vic; Mahaffey Kenneth W; Christenson Robert H; Harrington Robert A; Ohman E Magnus; Topol Eric J; Califf Robert M; Van de Werf Frans; Armstrong Paul W;
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.
Journal of the American College of Cardiology 2003;41(3):371-80.
2003: Selker Harry P; Raitt Merritt H; Schmid Christopher H; Laks Michael M; Beshansky Joni R; Griffith John L; Califf Robert M; Selvester Ronald H; Maynard Charles; D'Agostino Ralph B; Weaver W Douglas
Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction.
The American journal of cardiology 2003;91(3):280-6.
2003: Newby L K; Hasselblad V; Armstrong P W; Van de Werf F; Mark D B; White H D; Topol E J; Califf R M
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making.
European heart journal 2003;24(2):182-9.
2003: Newby L K; Bhapkar M V; White H D; Topol E J; Dougherty F C; Harrington R A; Smith M C; Asarch L F; Califf R M;
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.
European heart journal 2003;24(2):172-81.
2003: Califf R M
Cardiac markers in acute coronary syndromes-refining our knowledge.
European heart journal 2003;24(2):136-7.
2003: Yancy William S; Westman Eric C; French Patricia A; Califf Robert M
Diets and clinical coronary events: the truth is out there.
Circulation 2003;107(1):10-6.
2003: Al-Khatib Sana M; LaPointe Nancy M Allen; Curtis Lesley H; Kramer Judith M; Swann Joslyn; Honig Peter; Califf Robert M
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.
The American journal of cardiology 2003;91(1):91-4.
2002: Califf Robert M; Alexander Karen P
Cardiovascular research in the elderly: challenges, opportunities, and impact.
Postgraduate medicine 2002;112(6 Suppl Heart):6-11.
2002: Califf Robert M
Heart failure roundtable: beta-blockers in the elderly. Introduction.
Postgraduate medicine 2002;112(6 Suppl Heart):5.
2002: Mukherjee Debabrata; Mahaffey Kenneth W; Moliterno David J; Harrington Robert A; Yadav Jay S; Pieper Karen S; Gallup Dianne; Dyke Christopher; Roe Matthew T; Berdan Lisa; Lauer Michael S; Mänttäri Matti; White Harvey D; Califf Robert M; Topol Eric J
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
American heart journal 2002;144(6):995-1002.
2002: Newby L Kristin; Alpert Joseph S; Ohman E Magnus; Thygesen Kristian; Califf Robert M
Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.
American heart journal 2002;144(6):957-80.
2002: O'Shea J Conor; Wilcox Robert G; Skene Allan M; Stebbins Amanda L; Granger Christopher B; Armstrong Paul W; Bode Christoph; Ardissino Diego; Emanuelsson Hakan; Aylward Philip E; White Harvey D; Sadowski Zygmunt; Topol Eric J; Califf Robert M; Ohman E Magnus
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.
The American journal of cardiology 2002;90(12):1374-7.
2002: Califf Robert M; Peterson Eric D; Gibbons Raymond J; Garson Arthur; Brindis Ralph G; Beller George A; Smith Sidney C;
Integrating quality into the cycle of therapeutic development.
Journal of the American College of Cardiology 2002;40(11):1895-901.
2002: Blankenship James C; Balog Craig; Sapp Shelly K; Califf Robert M; Lincoff A Michael; Tcheng James E; Topol Eric J
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2002;57(4):476-83.
2002: Califf Robert M
Matching resources to treatment decisions for patients with acute coronary syndromes.
Clinical cardiology 2002;25(11 Suppl 1):I2-8.
2002: Anderson Mark E; Al-Khatib Sana M; Roden Dan M; Califf Robert M;
Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.
American heart journal 2002;144(5):769-81.
2002: Lincoff A Michael; Califf Robert M; Van de Werf Frans; Willerson James T; White Harvey D; Armstrong Paul W; Guetta Victor; Gibler W Brian; Hochman Judith S; Bode Christoph; Vahanian Alec; Steg P Gabriel; Ardissino Diego; Savonitto Stefano; Bar Frits; Sadowski Zygmunt; Betriu Amadeo; Booth Joan E; Wolski Kathy; Waller Michael; Topol Eric J;
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
JAMA : the journal of the American Medical Association 2002;288(17):2130-5.
2002: Islam M Ashequl; Blankenship James C; Balog Craig; Iliadis Elias A; Lincoff A Michael; Tcheng James E; Califf Robert M; Topol Eric J;
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).
The American journal of cardiology 2002;90(9):916-21.
2002: Lee Michael S; Wali Andreas U; Menon Venu; Berkowitz Scott D; Thompson Trevor D; Califf Robert M; Topol Eric J; Granger Christopher B; Hochman Judith S
The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb.
Journal of thrombosis and thrombolysis 2002;14(2):91-101.
2002: Schulman Kevin A; Seils Damon M; Timbie Justin W; Sugarman Jeremy; Dame Lauren A; Weinfurt Kevin P; Mark Daniel B; Califf Robert M
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.
The New England journal of medicine 2002;347(17):1335-41.
2002: Braunwald Eugene; Antman Elliott M; Beasley John W; Califf Robert M; Cheitlin Melvin D; Hochman Judith S; Jones Robert H; Kereiakes Dean; Kupersmith Joel; Levin Thomas N; Pepine Carl J; Schaeffer John W; Smith Earl E; Steward David E; Theroux Pierre; Gibbons Raymond J; Alpert Joseph S; Faxon David P; Fuster Valentin; Gregoratos Gabriel; Hiratzka Loren F; Jacobs Alice K; Smith Sidney C;
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology 2002;40(7):1366-74.
2002: Braunwald Eugene; Antman Elliott M; Beasley John W; Califf Robert M; Cheitlin Melvin D; Hochman Judith S; Jones Robert H; Kereiakes Dean; Kupersmith Joel; Levin Thomas N; Pepine Carl J; Schaeffer John W; Smith Earl E; Steward David E; Theroux Pierre; Gibbons Raymond J; Alpert Joseph S; Faxon David P; Fuster Valentin; Gregoratos Gabriel; Hiratzka Loren F; Jacobs Alice K; Smith Sidney C;
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Circulation 2002;106(14):1893-900.
2002: Califf Robert M
Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?
Statistics in medicine 2002;21(19):2889-97.
2002: James S; Armstrong P; Califf R; Husted S; Kontny F; Niemminen M; Pfisterer M; Simoons M L; Wallentin L
Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes.
European heart journal 2002;23(19):1538-45.
2002: Wong C-K; White H D; Wilcox R G; Criger D A; Califf R M; Topol E J; Ohman E M;
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
Heart (British Cardiac Society) 2002;88(4):357-62.
2002: Mehta Rajendra H; Criger Douglas A; Granger Christopher B; Pieper Karen K; Califf Robert M; Topol Eric J; Bates Eric R
Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability.
Journal of the American College of Cardiology 2002;40(6):1034-40; discussion 1041-3.
2002: Batchelor Wayne B; Tolleson Thaddeus R; Huang Yao; Larsen Rhonda L; Mantell R Michael; Dillard Patricia; Davidian Marie; Zhang Daowen; Cantor Warren J; Sketch Michael H; Ohman E Magnus; Zidar James P; Gretler Daniel; DiBattiste Peter M; Tcheng James E; Califf Robert M; Harrington Robert A
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
Circulation 2002;106(12):1470-6.
2002: Kereiakes Dean J; Lincoff A Michael; Anderson Keaven M; Achenbach Robert; Patel Kamlesh; Barnathan Elliot; Califf Robert M; Topol Eric J;
Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.
The American journal of cardiology 2002;90(6):628-30.
2002: Kong David F; Hasselblad Vic; Kandzari David E; Newby L Kristin; Califf Robert M
Seeking the optimal aspirin dose in acute coronary syndromes.
The American journal of cardiology 2002;90(6):622-5.
2002: Labinaz Marino; Madan Mina; O'Shea J O'Conor; Kilaru Rakhi; Chin Wai; Pieper Karen; McGuire Darren K; Saucedo Jorge F; Talley J David; Lui Henry; Kitt Michael M; Califf Robert M; Tcheng James T;
Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial).
The American journal of cardiology 2002;90(6):585-90.
2002: Hillegass William B; Brott Brigitta C; Chapman Gregory D; Phillips Harry R; Stack Richard S; Tcheng James E; Califf Robert M
Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications.
American heart journal 2002;144(3):501-7.
2002: Newby L Kristin; Harrington Robert A; Bhapkar Manjushri V; Van de Werf Frans; Hochman Judith S; Granger Christopher B; Simes R John; Davis Catherine G; Topol Eric J; Califf Robert M; Moliterno David J;
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.
Journal of thrombosis and thrombolysis 2002;14(1):33-42.
2002: Califf Robert M; DeMets David L
Principles from clinical trials relevant to clinical practice: Part II.
Circulation 2002;106(9):1172-5.
2002: Califf Robert M; DeMets David L
Principles from clinical trials relevant to clinical practice: Part I.
Circulation 2002;106(8):1015-21.
2002: Al Suwaidi Jassim; Reddan Donal N; Williams Kathryn; Pieper Karen S; Harrington Robert A; Califf Robert M; Granger Christopher B; Ohman E Magnus; Holmes David R;
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes.
Circulation 2002;106(8):974-80.
2002: Packer Milton; Califf Robert M; Konstam Marvin A; Krum Henry; McMurray John J; Rouleau Jean-Lucien; Swedberg Karl
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Circulation 2002;106(8):920-6.
2002: DeMets David L; Califf Robert M
Lessons learned from recent cardiovascular clinical trials: Part II.
Circulation 2002;106(7):880-6.
2002: LaPointe Nancy M Allen; Kramer Judith M; Weinfurt Kevin P; Califf Robert M
Practitioner acceptance of the dofetilide risk-management program.
Pharmacotherapy 2002;22(8):1041-6.
2002: Glassman Alexander H; O'Connor Christopher M; Califf Robert M; Swedberg Karl; Schwartz Peter; Bigger J Thomas; Krishnan K Ranga Rama; van Zyl Louis T; Swenson J Robert; Finkel Mitchell S; Landau Charles; Shapiro Peter A; Pepine Carl J; Mardekian Jack; Harrison Wilma M; Barton David; Mclvor Michael;
Sertraline treatment of major depression in patients with acute MI or unstable angina.
JAMA : the journal of the American Medical Association 2002;288(6):701-9.
2002: DeMets David L; Califf Robert M
Lessons learned from recent cardiovascular clinical trials: Part I.
Circulation 2002;106(6):746-51.
2002: Kent David M; Hayward Rodney A; Griffith John L; Vijan Sandeep; Beshansky Joni R; Califf Robert M; Selker Harry P
An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.
The American journal of medicine 2002;113(2):104-11.
2002: Kottke-Marchant K; Bahit M C; Granger C B; Zoldhelyi P; Ardissino D; Brooks L; Griffin J H; Potthoff R F; Van de Werf F; Califf R M; Topol E J
Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy.
European heart journal 2002;23(15):1202-12.
2002: Kandzari David E; Califf Robert M
TARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention.
Current opinion in cardiology 2002;17(4):332-9.
2002: Moya Martin P; Gow Andrew J; Califf Robert M; Goldberg Ronald N; Stamler Jonathan S
Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn.
Lancet 2002;360(9327):141-3.
2002: Whellan David J; Cohen Elizabeth J; Matchar David B; Califf Robert M
Disease management in healthcare organizations: results of in-depth interviews with disease management decision makers.
The American journal of managed care 2002;8(7):633-41.
2002: Al-Khatib Sana M; Granger Christopher B; Huang Yao; Lee Kerry L; Califf Robert M; Simoons Maarten L; Armstrong Paul W; Van de Werf Frans; White Harvey D; Simes R John; Moliterno David J; Topol Eric J; Harrington Robert A
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Circulation 2002;106(3):309-12.
2002: O'Connor Christopher M; Velazquez Eric J; Gardner Laura H; Smith Peter K; Newman Mark F; Landolfo Kevin P; Lee Kerry L; Califf Robert M; Jones Robert H
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank).
The American journal of cardiology 2002;90(2):101-7.
2002: Topol Eric J; Lincoff A Michael; Kereiakes Dean J; Kleiman Neal S; Cohen Eric A; Ferguson James J; Tcheng James E; Sapp Shelly; Califf Robert M
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization.
The American journal of medicine 2002;113(1):1-6.
2002: Anderson R David; White Harvey D; Ohman E Magnus; Wagner Galen S; Krucoff Mitchell W; Armstrong Paul W; Weaver W Douglas; Gibler W Brian; Stebbins Amanda L; Califf Robert M; Topol Eric J
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.
American heart journal 2002;144(1):81-8.
2002: Gilchrist Ian C; Berkowitz Scott D; Thompson Trevor D; Califf Robert M; Granger Christopher B
Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global Use of Strategies to Open Occluded Coronary Arteries.
American heart journal 2002;144(1):73-80.
2002: Chang W-C; Harrington R A; Simoons M L; Califf R M; Lincoff A M; Armstrong P W;
Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial.
European heart journal 2002;23(14):1102-11.
2002: Califf Robert M
The need for a national infrastructure to improve the rational use of therapeutics.
Pharmacoepidemiology and drug safety 2002;11(4):319-27.
2002: Aviles Ronnier J; Askari Arman T; Lindahl Bertil; Wallentin Lars; Jia Gang; Ohman E Magnus; Mahaffey Kenneth W; Newby L Kristin; Califf Robert M; Simoons Maarten L; Topol Eric J; Berger Peter; Lauer Michael S
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.
The New England journal of medicine 2002;346(26):2047-52.
2002: Ronner Eelko; Boersma Eric; Laarman Gert-Jan; Somsen G Aernout; Harrington Robert A; Deckers Jaap W; Topol Eric J; Califf Robert M; Simoons Maarten L
Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy.
Journal of the American College of Cardiology 2002;39(12):1924-9.
2002: Newby L Kristin; Kristinsson Arni; Bhapkar Manjushri V; Aylward Philip E; Dimas Alexios P; Klein Werner W; McGuire Darren K; Moliterno David J; Verheugt Freek W A; Weaver W Douglas; Califf Robert M;
Early statin initiation and outcomes in patients with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2002;287(23):3087-95.
2002: Cantor Warren J; Newby L Kristin; Christenson Robert H; Tuttle Robert H; Hasselblad Vic; Armstrong Paul W; Moliterno David J; Califf Robert M; Topol Eric J; Ohman E Magnus;
Prognostic significance of elevated troponin I after percutaneous coronary intervention.
Journal of the American College of Cardiology 2002;39(11):1738-44.
2002: Newby L Kristin; Califf Robert M; White Harvey D; Harrington Robert A; Van de Werf Frans; Granger Christopher B; Simes R John; Hasselblad Vic; Armstrong Paul W
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.
The American journal of medicine 2002;112(8):647-58.
2002: Shah Monica R; Hasselblad Vic; Stinnett Sandra S; Kramer Judith M; Grossman Steven; Gheorghiade Mihai; Adams Kirkwood F; Swedberg Karl; Califf Robert M; O'Connor Christopher M
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(3):297-304.
2002: Szczech L A; Best P J; Crowley E; Brooks M M; Berger P B; Bittner V; Gersh B J; Jones R; Califf R M; Ting H H; Whitlow P J; Detre K M; Holmes D;
Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.
Circulation 2002;105(19):2253-8.
2002: Allen LaPointe Nancy M; Kramer Judith M; DeLong Elizabeth R; Ostbye Truls; Hammill Bradley G; Muhlbaier Lawrence H; McCants Charles B; Chen Anita; Califf Robert M
Patient-reported frequency of taking aspirin in a population with coronary artery disease.
The American journal of cardiology 2002;89(9):1042-6.
2002: Kip Kevin E; Alderman Edwin L; Bourassa Martial G; Brooks Maria Mori; Schwartz Leonard; Holmes David R; Califf Robert M; Whitlow Patrick L; Chaitman Bernard R; Detre Katherine M
Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation.
Circulation 2002;105(16):1914-20.
2002: Califf Robert M
The coxib story: some lessons and more questions.
The American journal of cardiology 2002;89(8):971-2.
2002: Cuffe Michael S; Califf Robert M; Adams Kirkwood F; Benza Raymond; Bourge Robert; Colucci Wilson S; Massie Barry M; O'Connor Christopher M; Pina Ileana; Quigg Rebecca; Silver Marc A; Gheorghiade Mihai;
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2002;287(12):1541-7.
2002: Califf Robert M; DeLong Elizabeth R; Ostbye Truls; Muhlbaier Lawrence H; Chen Anita; LaPointe Nancy Allen; Hammill Bradley G; McCants Charles B; Kramer Judith M
Underuse of aspirin in a referral population with documented coronary artery disease.
The American journal of cardiology 2002;89(6):653-61.
2002: Mahaffey Kenneth W; Roe Matthew T; Dyke Christopher K; Newby L Kristin; Kleiman Neal S; Connolly Patty; Berdan Lisa G; Sparapani Rodney; Lee Kerry L; Armstrong Paul W; Topol Eric J; Califf Robert M; Harrington Robert A
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.
American heart journal 2002;143(2):242-8.
2002: Califf Robert M
Publication policy, informed consent, and the randomized clinical trial.
American heart journal 2002;143(2):187-8.
2002: O'Shea J Conor; Buller Christopher E; Cantor Warren J; Chandler A Bleakley; Cohen Eric A; Cohen David J; Gilchrist Ian C; Kleiman Neal S; Labinaz Marino; Madan Mina; Hafley Gail E; Califf Robert M; Kitt Michael M; Strony John; Tcheng James E;
Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.
JAMA : the journal of the American Medical Association 2002;287(5):618-21.
2002: Gibler W Brian; Armstrong Paul W; Ohman E Magnus; Weaver W Douglas; Stebbins Amanda L; Gore Joel M; Newby L Kristin; Califf Robert M; Topol Eric J;
Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience.
Annals of emergency medicine 2002;39(2):123-30.
2002: Ronner E; Boersma E; Akkerhuis K M; Harrington R A; Lincoff A M; Deckers J W; Karsch K; Kleiman N S; Vahanian A; Topol E J; Califf R M; Simoons M L
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker.
European heart journal 2002;23(3):239-46.
2002: Boersma Eric; Harrington Robert A; Moliterno David J; White Harvey; Théroux Pierre; Van de Werf Frans; de Torbal Anneke; Armstrong Paul W; Wallentin Lars C; Wilcox Robert G; Simes John; Califf Robert M; Topol Eric J; Simoons Maarten L
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Lancet 2002;359(9302):189-98.
2002: Labinaz Marino; Kilaru Rakhi; Pieper Karen; Marso Steven P; Kitt Michael M; Simoons Maarten L; Califf Robert M; Topol Eric J; Armstrong Paul W; Harrington Robert A
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation 2002;105(3):322-7.
2002: Savonitto Stefano; Granger Christopher B; Ardissino Diego; Gardner Laura; Cavallini Claudio; Galvani Marcello; Ottani Filippo; White Harvey D; Armstrong Paul W; Ohman E Magnus; Pieper Karen S; Califf Robert M; Topol Eric J;
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes.
Journal of the American College of Cardiology 2002;39(1):22-9.
2002: Breeman Arno; Mercado Nestor; Lenzen Mattie; van den Brand Marcel M J; Harrington Robert A; Califf Robert M; Topol Eric J; Simoons Maarten L; Boersma Eric;
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).
Cardiology 2002;98(4):195-201.
2002: Birnbaum Yochai; Mahaffey Kenneth W; Criger Douglas A; Gates Kathy B; Barbash Gabriel I; Barbagelata Alejandro; Clemmensen Peter; Sgarbossa Elena B; Gibbons Raymond J; Rahman M Atiar; Califf Robert M; Granger Chistopher B; Wagner Galen S;
Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis.
Cardiology 2002;97(3):166-74.
2001: Dolor R J; Witsell D L; Hellkamp A S; Williams J W; Califf R M; Simel D L;
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;286(24):3097-105.
2001: Roe M T; Granger C B; Puma J A; Hellkamp A S; Hochman J S; Ohman E M; White H D; Van de Werf F; Armstrong P W; Ellis S G; Califf R M; Topol E J
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
The American journal of cardiology 2001;88(12):1403-6, A6.
2001: Roffi M; Chew D P; Mukherjee D; Bhatt D L; White J A; Heeschen C; Hamm C W; Moliterno D J; Califf R M; White H D; Kleiman N S; Théroux P; Topol E J
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes.
Circulation 2001;104(23):2767-71.
2001: Van de Werf F; Barron H V; Armstrong P W; Granger C B; Berioli S; Barbash G; Pehrsson K; Verheugt F W; Meyer J; Betriu A; Califf R M; Li X; Fox N L;
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.
European heart journal 2001;22(24):2253-61.
2001: Donahue M; Fuster V; Califf R M
Results of Expert Meetings: Obesity and Cardiovascular Disease. Introduction: Cardiologists should target obesity.
American heart journal 2001;142(6):1088-90.
2001: Shah M R; Hasselblad V; Gheorghiade M; Adams K F; Swedberg K; Califf R M; O'Connor C M
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy.
The American journal of cardiology 2001;88(9):987-93.
2001: Tcheng J E; Talley J D; O'Shea J C; Gilchrist I C; Kleiman N S; Grines C L; Davidson C J; Lincoff A M; Califf R M; Jennings L K; Kitt M M; Lorenz T J
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).
The American journal of cardiology 2001;88(10):1097-102.
2001: Kandzari D E; Lam L C; Eisenstein E L; Clapp-Channing N; Fine J T; Califf R M; Mark D B; Jollis J G
Advanced coronary artery disease: Appropriate end points for trials of novel therapies.
American heart journal 2001;142(5):843-51.
2001: Birnbaum Y; Goodman S; Barr A; Gates K B; Barbash G I; Battler A; Barbagelata A; Clemmensen P; Sgarbossa E B; Granger C B; Califf R M; Wagner G S
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram.
The American journal of cardiology 2001;88(8):842-7.
2001: Hudson M P; Granger C B; Topol E J; Pieper K S; Armstrong P W; Barbash G I; Guerci A D; Vahanian A; Califf R M; Ohman E M
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Circulation 2001;104(11):1229-35.
2001: O'Connor C M; Gattis W A; Hellkamp A S; Langer A; Larsen R L; Harrington R A; Berkowitz S D; O'Gara P T; Kopecky S L; Gheorghiade M; Daly R; Califf R M; Fuster V
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
The American journal of cardiology 2001;88(5):541-6.
2001: DeLong E R; Nelson C L; Wong J B; Pryor D B; Peterson E D; Lee K L; Mark D B; Califf R M; Pauker S G
Using observational data to estimate prognosis: an example using a coronary artery disease registry.
Statistics in medicine 2001;20(16):2505-32.
2001: Jiang W; Alexander J; Christopher E; Kuchibhatla M; Gaulden L H; Cuffe M S; Blazing M A; Davenport C; Califf R M; Krishnan R R; O'Connor C M
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.
Archives of internal medicine 2001;161(15):1849-56.
2001: Blazing M A; De Lemos J A; Dyke C K; Califf R M; Bilheimer D; Braunwald E
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy.
American heart journal 2001;142(2):211-7.
2001: Kaul P; Fu Y; Chang W C; Harrington R A; Wagner G S; Goodman S G; Granger C B; Moliterno D J; Van de Werf F; Califf R M; Topol E J; Armstrong P W;
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network.
Journal of the American College of Cardiology 2001;38(1):64-71.
2001: Alexander K P; Newby L K; Hellkamp A S; Harrington R A; Peterson E D; Kopecky S; Langer A; O'Gara P; O'Connor C M; Daly R N; Califf R M; Khan S; Fuster V
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
Journal of the American College of Cardiology 2001;38(1):1-7.
2001: Akkerhuis K M; Deckers J W; Lincoff A M; Tcheng J E; Boersma E; Anderson K; Balog C; Califf R M; Topol E J; Simoons M L
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention.
JAMA : the journal of the American Medical Association 2001;286(1):78-82.
2001: Whellan D J; Shaw L K; Bart B A; Kraus W E; Califf R M; O'Connor C M
Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction.
American heart journal 2001;142(1):160-6.
2001: Lundergan C F; Ross A M; McCarthy W F; Reiner J S; Boyle D; Fink C; Califf R M; Topol E J; Simoons M L; Van Den Brand M; Van de Werf F; Coyne K S;
Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience.
American heart journal 2001;142(1):43-50.
2001: Al-Khatib S M; Pieper K S; Lee K L; Mahaffey K W; Hochman J S; Pepine C J; Kopecky S L; Akkerhuis M; Stepinska J; Simoons M L; Topol E J; Califf R M; Harrington R A
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial.
The American journal of cardiology 2001;88(1):A7, 76-9.
2001: Szczech L A; Reddan D N; Owen W F; Califf R; Racz M; Jones R H; Hannan E L
Differential survival after coronary revascularization procedures among patients with renal insufficiency.
Kidney international 2001;60(1):292-9.
2001: Shah M R; Hasselblad V; Stinnett S S; Gheorghiade M; Swedberg K; Califf R M; O'Connor C M
Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes.
Journal of cardiac failure 2001;7(2):105-13.
2001: Anderson K M; Califf R M; Stone G W; Neumann F J; Montalescot G; Miller D P; Ferguson J J; Willerson J T; Weisman H F; Topol E J
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.
Journal of the American College of Cardiology 2001;37(8):2059-65.
2001: Newby L K; Ohman E M; Christenson R H; Moliterno D J; Harrington R A; White H D; Armstrong P W; Van De Werf F; Pfisterer M; Hasselblad V; Califf R M; Topol E J
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
Circulation 2001;103(24):2891-6.
2001: Al-Khatib S M; Califf R M; Hasselblad V; Alexander J H; McCrory D C; Sugarman J
Medicine. Placebo-controls in short-term clinical trials of hypertension.
Science (New York, N.Y.) 2001;292(5524):2013-5.
2001: Cantor W J; Hellkamp A S; Peterson E D; Zidar J P; Cowper P A; Sketch M H; Tcheng J E; Califf R M; Ohman E M
Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes?
Journal of the American College of Cardiology 2001;37(7):1883-90.
2001: Shah M R; Stinnett S S; McNulty S E; Gheorghiade M; Zannad F; Uretsky B; Adams K F; Califf R M; O'connor C M
Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST.
American heart journal 2001;141(6):908-14.
2001: O'Shea J C; Califf R M
International differences in treatment effects in cardiovascular clinical trials.
American heart journal 2001;141(5):875-80.
2001: O'Shea J C; Califf R M
International differences in cardiovascular clinical trials.
American heart journal 2001;141(5):866-74.
2001: O'Shea J C; Califf R M
International differences in cardiovascular clinical trials. Introduction.
American heart journal 2001;141(5):864-5.
2001: Mast S T; Gersing K R; Anstrom K J; Krishnan K R; Califf R M; Jollis J G
Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation.
The American journal of cardiology 2001;87(8):989-93: A4.
2001: Aronow H D; Topol E J; Roe M T; Houghtaling P L; Wolski K E; Lincoff A M; Harrington R A; Califf R M; Ohman E M; Kleiman N S; Keltai M; Wilcox R G; Vahanian A; Armstrong P W; Lauer M S
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.
Lancet 2001;357(9262):1063-8.
2001: Pilote L; Miller D P; Califf R M; Topol E J;
Recurrent ischemia after thrombolysis for acute myocardial infarction.
American heart journal 2001;141(4):559-65.
2001: Shah M R; O'Connor C M; Sopko G; Hasselblad V; Califf R M; Stevenson L W
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale.
American heart journal 2001;141(4):528-35.
2001: Bahit M C; Topol E J; Califf R M; Armstrong P W; Criger D A; Hasselblad V; Betriu A; Hirsh J; Ardissino D; Granger C B
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
Journal of the American College of Cardiology 2001;37(4):1001-7.
2001: Morse M A; Califf R M; Sugarman J
Monitoring and ensuring safety during clinical research.
JAMA : the journal of the American Medical Association 2001;285(9):1201-5.
2001: Labinaz M; Sketch M H; Ellis S G; Abramowitz B M; Stebbins A L; Pieper K S; Holmes D R; Califf R M; Topol E J
Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy.
American heart journal 2001;141(3):469-77.
2001: Cohen M G; Pacchiana C M; Corbalán R; Perez J E; Ponte C I; Oropeza E S; Diaz R; Paolasso E; Izasa D; Rodas M A; Urrutia C E; Harrington R A; Topol E J; Califf R M
Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial.
American heart journal 2001;141(3):391-401.
2001: Peterson J G; Topol E J; Roe M T; Sapp S K; Lincoff A M; Deckers J W; Blackstone E H; Harrington R A; Califf R M; Lauer M S
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
The American journal of cardiology 2001;87(5):532-6.
2001: Greenbaum A B; Harrington R A; Hudson M P; MacAulay C M; Wilcox R G; Simoons M L; Berdan L G; Guerci A; Cokkinos D V; Kitt M M; Lincoff A M; Topol E J; Califf R M; Ohman E M
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.
Journal of the American College of Cardiology 2001;37(2):492-8.
2001: Barbash G I; Birnbaum Y; Bogaerts K; Hudson M; Lesaffre E; Fu Y; Goodman S; Houbracken K; Munsters K; Granger C B; Pieper K; Califf R M; Topol E J; Van De Werf F
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
Circulation 2001;103(7):954-60.
2001: Califf R M; Ellenberg S S
Statistical approaches and policies for the operations of Data and Safety Monitoring Committees.
American heart journal 2001;141(2):301-5.
2001: Savonitto S; Fusco R; Granger C B; Cohen M G; Thompson T D; Ardissino D; Califf R M
Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2001;6(1):64-77.
2001: Roe M T; Ohman E M; Maas A C; Christenson R H; Mahaffey K W; Granger C B; Harrington R A; Califf R M; Krucoff M W
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.
Journal of the American College of Cardiology 2001;37(1):9-18.
2001: Califf R M; Lee K L
Data and safety monitoring committees: philosophy and practice.
American heart journal 2001;141(1):154-5.
2000: Califf R M
Introduction: evidence to practice in acute coronary syndromes.
The American journal of cardiology 2000;86(12B):1M-3M.
2000: Campbell K R; Mahaffey K W; Lewis B E; Weitz J I; Berkowitz S D; Ohman E M; Califf R M
Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
The Journal of invasive cardiology 2000;12 Suppl F():14F-9.
2000: Auerbach A D; Hamel M B; Califf R M; Davis R B; Wenger N S; Desbiens N; Goldman L; Vidaillet H; Connors A F; Lynn J; Dawson N V; Phillips R S
Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Journal of the American College of Cardiology 2000;36(7):2119-25.
2000: Greenbaum A B; Califf R M; Jones R H; Gardner L H; Phillips H R; Sketch M H; Stack R S; Puma J A
Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease.
The American journal of cardiology 2000;86(12):1322-6.
2000: Marso S P; Bhatt D L; Roe M T; Houghtaling P L; Labinaz M; Kleiman N S; Dyke C; Simmoons M L; Califf R M; Harrington R A; Topol E J
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators.
Circulation 2000;102(24):2952-8.
2000: Lincoff A M; Mark D B; Tcheng J E; Califf R M; Bala M V; Anderson K M; Davidson-Ray L; Knight J D; Cabot C F; Topol E J
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
Circulation 2000;102(24):2923-9.
2000: Califf R M; Eisenstein E L
Critical concepts in cost-effectiveness for cardiovascular specialists.
American heart journal 2000;140(6 Suppl):S143-7.
2000: Wong C K; White H D; Wilcox R G; Criger D A; Califf R M; Topol E J; Ohman E M
New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience.
American heart journal 2000;140(6):878-85.
2000: Menon V; Hochman J S; Stebbins A; Pfisterer M; Col J; Anderson R D; Hasdai D; Holmes D R; Bates E R; Topol E J; Califf R M; Ohman E M
Lack of progress in cardiogenic shock: lessons from the GUSTO trials.
European heart journal 2000;21(23):1928-36.
2000: Herrmann H C; Moliterno D J; Ohman E M; Stebbins A L; Bode C; Betriu A; Forycki F; Miklin J S; Bachinsky W B; Lincoff A M; Califf R M; Topol E J
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial.
Journal of the American College of Cardiology 2000;36(5):1489-96.
2000: Pfeffer M A; McMurray J; Leizorovicz A; Maggioni A P; Rouleau J L; Van De Werf F; Henis M; Neuhart E; Gallo P; Edwards S; Sellers M A; Velazquez E; Califf R
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.
American heart journal 2000;140(5):727-50.
2000: McGuire D K; Emanuelsson H; Granger C B; Magnus Ohman E; Moliterno D J; White H D; Ardissino D; Box J W; Califf R M; Topol E J
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators.
European heart journal 2000;21(21):1750-8.
2000: Chang W C; Fu Y; Ohman E M; Gupta M; Morris A; Roth S N; Granger C B; Califf R M; Topol E J; Mark D B; Armstrong P W
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.
The Canadian journal of cardiology 2000;16(10):1231-9.
2000: Shah M R; Granger C B; Bart B A; McMurray J J; Petrie M C; Michelson E L; Tudor G E; Swedberg K; Stevenson L W; Califf R M; Pfeffer M A
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry.
The American journal of medicine 2000;109(6):489-92.
2000: O'Connor C M; Gattis W A; Shaw L; Cuffe M S; Califf R M
Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function.
The American journal of cardiology 2000;86(8):863-7.
2000: Birnbaum Y; Wagner G S; Gates K B; Thompson T D; Barbash G I; Siegel R J; Granger C B; Fishbein M C; Crenshaw B S; Califf R M
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction.
The American journal of cardiology 2000;86(8):830-4.
2000: Topol E J; Ohman E M; Armstrong P W; Wilcox R; Skene A M; Aylward P; Simes J; Dalby A; Betriu A; Bode C; White H D; Hochman J S; Emanuelson H; Vahanian A; Sapp S; Stebbins A; Moliterno D J; Califf R M
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Circulation 2000;102(15):1761-5.
2000: Califf R M
Genetics, genomics, proteomics: what is a cardiologist to do?
American heart journal 2000;140(4):S48-50.
2000: Fu Y; Chang W C; Mark D; Califf R M; Mackenzie B; Granger C B; Topol E J; Hlatky M; Armstrong P W
Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.
Circulation 2000;102(12):1375-81.
2000: Califf R M
Cigarette smoking: how much worse can it get?
Circulation 2000;102(12):1340-1.
2000: Braunwald E; Antman E M; Beasley J W; Califf R M; Cheitlin M D; Hochman J S; Jones R H; Kereiakes D; Kupersmith J; Levin T N; Pepine C J; Schaeffer J W; Smith E E; Steward D E; Theroux P; Alpert J S; Eagle K A; Faxon D P; Fuster V; Gardner T J; Gregoratos G; Russell R O; Smith S C
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology 2000;36(3):970-1062.
2000: Goodman S G; Cohen M; Bigonzi F; Gurfinkel E P; Radley D R; Le Iouer V; Fromell G J; Demers C; Turpie A G; Califf R M; Fox K A; Langer A
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.
Journal of the American College of Cardiology 2000;36(3):693-8.
2000: Hasdai D; Harrington R A; Hochman J S; Califf R M; Battler A; Box J W; Simoons M L; Deckers J; Topol E J; Holmes D R
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation.
Journal of the American College of Cardiology 2000;36(3):685-92.
2000: Braunwald E; Antman E M; Beasley J W; Califf R M; Cheitlin M D; Hochman J S; Jones R H; Kereiakes D; Kupersmith J; Levin T N; Pepine C J; Schaeffer J W; Smith E E; Steward D E; Theroux P; Gibbons R J; Alpert J S; Eagle K A; Faxon D P; Fuster V; Gardner T J; Gregoratos G; Russell R O; Smith S C
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).
Circulation 2000;102(10):1193-209.
2000: Roe M T; Harrington R A; Prosper D M; Pieper K S; Bhatt D L; Lincoff A M; Simoons M L; Akkerhuis M; Ohman E M; Kitt M M; Vahanian A; Ruzyllo W; Karsch K; Califf R M; Topol E J
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
Circulation 2000;102(10):1101-6.
2000: Lincoff A M; Harrington R A; Califf R M; Hochman J S; Guerci A D; Ohman E M; Pepine C J; Kopecky S L; Kleiman N S; Pacchiana C M; Berdan L G; Kitt M M; Simoons M L; Topol E J
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation 2000;102(10):1093-100.
2000: Sgarbossa E B; Meyer P M; Pinski S L; Pavlovic-Surjancev B; Barbagelata A; Goodman S G; Lum A S; Underwood D A; Gates K B; Califf R M; Topol E J; Wagner G S
Negative T waves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rate.
American heart journal 2000;140(3):385-94.
2000: Hasdai D; Topol E J; Califf R M; Berger P B; Holmes D R
Cardiogenic shock complicating acute coronary syndromes.
Lancet 2000;356(9231):749-56.
2000: Lincoff A M; LeNarz L A; Despotis G J; Smith P K; Booth J E; Raymond R E; Sapp S K; Cabot C F; Tcheng J E; Califf R M; Effron M B; Topol E J
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing.
The Annals of thoracic surgery 2000;70(2):516-26.
2000: Harrington R A; Armstrong P W; Graffagnino C; Van De Werf F; Kereiakes D J; Sigmon K N; Card T; Joseph D M; Samuels R; Granett J; Chan R; Califf R M; Topol E J
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.
Circulation 2000;102(7):728-35.
2000: Cho L; Topol E J; Balog C; Foody J M; Booth J E; Cabot C; Kleiman N S; Tcheng J E; Califf R; Lincoff A M
Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent.
Journal of the American College of Cardiology 2000;36(2):381-6.
2000: Kleiman N S; Califf R M
Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. American College of Cardiology.
Journal of the American College of Cardiology 2000;36(1):310-25.
2000: Sane D C; Damaraju L V; Topol E J; Cabot C F; Mascelli M A; Harrington R A; Simoons M L; Califf R M
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy.
Journal of the American College of Cardiology 2000;36(1):75-83.
2000: Kereiakes D J; Berkowitz S D; Lincoff A M; Tcheng J E; Wolski K; Achenbach R; Melsheimer R; Anderson K; Califf R M; Topol E J
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
American heart journal 2000;140(1):74-80.
2000: Brieger D B; Mak K H; Miller D P; Califf R M; Topol E J
Hierarchy of risk based on history and location of prior myocardial infarction in the thrombolytic era. GUSTO-I Investigators.
American heart journal 2000;140(1):29-33.
2000: Califf R M
Dual randomization in cardiovascular trials.
American heart journal 2000;140(1):1.
2000: Barbagelata A; Califf R M; Sgarbossa E B; Goodman S G; Knight D; Mark D B; Granger C B; Agranatti D A; Mautner B; Ohman E M; Suárez L D; Armstrong P W; Gates K; Wagner G S
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).
The American journal of cardiology 2000;86(1):24-9.
2000: Brooks M M; Jones R H; Bach R G; Chaitman B R; Kern M J; Orszulak T A; Follmann D; Sopko G; Blackstone E H; Califf R M
Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators.
Circulation 2000;101(23):2682-9.
2000: Boersma E; Pieper K S; Steyerberg E W; Wilcox R G; Chang W C; Lee K L; Akkerhuis K M; Harrington R A; Deckers J W; Armstrong P W; Lincoff A M; Califf R M; Topol E J; Simoons M L
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.
Circulation 2000;101(22):2557-67.
2000: Cohen M; Stinnett S S; Weatherley B D; Gurfinkel E P; Fromell G J; Goodman S G; Fox K A; Califf R M
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
American heart journal 2000;139(6):962-70.
2000: Topol E J; Easton J D; Amarenco P; Califf R; Harrington R; Graffagnino C; Davis S; Diener H C; Ferguson J; Fitzgerald D; Shuaib A; Koudstaal P J; Theroux P; Van de Werf F; Willerson J T; Chan R; Samuels R; Ilson B; Granett J
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
American heart journal 2000;139(6):927-33.
2000: Velazquez E J; Califf R M
All that glitters is not gold.
Lancet 2000;355(9215):1568-9.
2000: Califf R M; Pieper K S; Lee K L; Van De Werf F; Simes R J; Armstrong P W; Topol E J
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial.
Circulation 2000;101(19):2231-8.
2000: Puchalski C M; Zhong Z; Jacobs M M; Fox E; Lynn J; Harrold J; Galanos A; Phillips R S; Califf R; Teno J M
Patients who want their family and physician to make resuscitation decisions for them: observations from SUPPORT and HELP. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Hospitalized Elderly Longitudinal Project.
Journal of the American Geriatrics Society 2000;48(5 Suppl):S84-90.
2000: Wenger N S; Phillips R S; Teno J M; Oye R K; Dawson N V; Liu H; Califf R; Layde P; Hakim R; Lynn J
Physician understanding of patient resuscitation preferences: insights and clinical implications.
Journal of the American Geriatrics Society 2000;48(5 Suppl):S44-51.
2000: Hasdai D; Granger C B; Srivatsa S S; Criger D A; Ellis S G; Califf R M; Topol E J; Holmes D R
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes.
Journal of the American College of Cardiology 2000;35(6):1502-12.
2000: Hasdai D; Holmes D R; Criger D A; Topol E J; Califf R M; Harrington R A
Age and outcome after acute coronary syndromes without persistent ST-segment elevation.
American heart journal 2000;139(5):858-66.
2000: Bhatt D L; Lincoff A M; Califf R M; Simoons M L; Tcheng J E; Brener S J; Wolski K E; Topol E J
The benefit of abciximab in percutaneous coronary revascularization is not device-specific.
The American journal of cardiology 2000;85(9):1060-4.
2000: Akkerhuis K M; Maas A C; Klootwijk P A; Krucoff M W; Meij S; Califf R M; Simoons M L
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
Journal of electrocardiology 2000;33(2):127-36.
2000: Lincoff A M; Califf R M; Topol E J
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
Journal of the American College of Cardiology 2000;35(5):1103-15.
2000: Newby L K; Kaplan A L; Granger B B; Sedor F; Califf R M; Ohman E M
Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit.
The American journal of cardiology 2000;85(7):801-5.
2000: Granger C B; Ertl G; Kuch J; Maggioni A P; McMurray J; Rouleau J L; Stevenson L W; Swedberg K; Young J; Yusuf S; Califf R M; Bart B A; Held P; Michelson E L; Sellers M A; Ohlin G; Sparapani R; Pfeffer M A
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
American heart journal 2000;139(4):609-17.
2000: Gent M; Califf R M
Chronic ischemic heart disease.
American heart journal 2000;139(4):S182-8.
2000: Batchelor W B; Granger C B; Kleiman N S; Phillips H R; Ellis S G; Betriu A; Criger D A; Stebbins A L; Topol E J; Califf R M;
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes.
The American journal of cardiology 2000;85(6):692-7.
2000: Christenson R H; Vollmer R T; Ohman E M; Peck S; Thompson T D; Duh S H; Ellis S G; Newby L K; Topol E J; Califf R M
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
The American journal of cardiology 2000;85(5):543-7.
2000: Eisenstein E L; Peterson E D; Jollis J G; Tardiff B E; Califf R M; Knight J D; Mark D B
Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome.
PharmacoEconomics 2000;17(3):263-72.
2000: Newby L K; Eisenstein E L; Califf R M; Thompson T D; Nelson C L; Peterson E D; Armstrong P W; Van de Werf F; White H D; Topol E J; Mark D B
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.
The New England journal of medicine 2000;342(11):749-55.
2000: Shah A; Wagner G S; Granger C B; O'Connor C M; Green C L; Trollinger K M; Califf R M; Krucoff M W
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment.
Journal of the American College of Cardiology 2000;35(3):666-72.
2000: Califf R M; O'Connor C M
Beta-blocker therapy for heart failure: the evidence is in, now the work begins.
JAMA : the journal of the American Medical Association 2000;283(10):1335-7.
2000: Brener S J; Ellis S G; Sapp S K; Betriu A; Granger C B; Burchenal J E; Moliterno D J; Califf R M; Topol E J
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials.
American heart journal 2000;139(3):476-81.
2000: Hasdai D; Holmes D R; Criger D A; Topol E J; Califf R M; Wilcox R G; Paolasso E; Simoons M; Deckers J; Harrington R A
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators.
American heart journal 2000;139(3):454-60.
2000: Akkerhuis K M; Deckers J W; Boersma E; Harrington R A; Stepinska J; Mahaffey K W; Wilcox R G; Lincoff A M; Keltai M; Topol E J; Califf R M; Simoons M L
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT.
European heart journal 2000;21(5):371-81.
2000: Thel M C; Califf R M; Tardiff B E; Gardner L H; Sigmon K N; Lincoff A M; Topol E J; Kitt M M; Blankenship J C; Tcheng J E
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
The American journal of cardiology 2000;85(4):427-34.
2000: Kleiman N S; Lincoff A M; Flaker G C; Pieper K S; Wilcox R G; Berdan L G; Lorenz T J; Cokkinos D V; Simoons M L; Boersma E; Topol E J; Califf R M; Harrington R A
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators.
Circulation 2000;101(7):751-7.
2000: Mark D B; Harrington R A; Lincoff A M; Califf R M; Nelson C L; Tsiatis A A; Buell H; Mahaffey K W; Davidson-Ray L; Topol E J
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes.
Circulation 2000;101(4):366-71.
2000: Auerbach A D; Hamel M B; Davis R B; Connors A F; Regueiro C; Desbiens N; Goldman L; Califf R M; Dawson N V; Wenger N; Vidaillet H; Phillips R S
Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Annals of internal medicine 2000;132(3):191-200.
2000: Califf R M
Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition.
American heart journal 2000;139(2 Pt 2):S33-7.
2000: Braunwald E; Califf R M; Cannon C P; Fox K A; Fuster V; Gibler W B; Harrington R A; King S B; Kleiman N S; Theroux P; Topol E J; Van de Werf F; White H D; Willerson J T
Redefining medical treatment in the management of unstable angina.
The American journal of medicine 2000;108(1):41-53.
2000: Phillips R S; Hamel M B; Teno J M; Soukup J; Lynn J; Califf R; Vidaillet H; Davis R B; Bellamy P; Goldman L
Patient race and decisions to withhold or withdraw life-sustaining treatments for seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
The American journal of medicine 2000;108(1):14-9.
2000: Alexander J H; Sparapani R A; Mahaffey K W; Deckers J W; Newby L K; Ohman E M; Corbalán R; Chierchia S L; Boland J B; Simoons M L; Califf R M; Topol E J; Harrington R A
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
JAMA : the journal of the American Medical Association 2000;283(3):347-53.
2000: Hasdai D; Califf R M; Thompson T D; Hochman J S; Ohman E M; Pfisterer M; Bates E R; Vahanian A; Armstrong P W; Criger D A; Topol E J; Holmes D R
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.
Journal of the American College of Cardiology 2000;35(1):136-43.
2000: Califf R M; Cohn J N
Cardiac protection: evolving role of angiotensin receptor blockers.
American heart journal 2000;139(1 Pt 2):S15-22.
2000: Cuffe M S; Califf R M; Adams K F; Bourge R C; Colucci W; Massie B; O'Connor C M; Pina I; Quigg R; Silver M; Robinson L A; Leimberger J D; Gheorghiade M
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.
American heart journal 2000;139(1 Pt 1):15-22.
2000: Crenshaw B S; Granger C B; Birnbaum Y; Pieper K S; Morris D C; Kleiman N S; Vahanian A; Califf R M; Topol E J
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators.
Circulation 2000;101(1):27-32.
2000: Kleiman N S; Tracy R P; Talley J D; Sigmon K; Joseph D; Topol E J; Califf R M; Kitt M; Ohman E M
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.
Journal of thrombosis and thrombolysis 2000;9(1):5-12.
1999: Topol E J; Mark D B; Lincoff A M; Cohen E; Burton J; Kleiman N; Talley D; Sapp S; Booth J; Cabot C F; Anderson K M; Califf R M
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
Lancet 1999;354(9195):2019-24.
1999: Ohman E M; Armstrong P W; White H D; Granger C B; Wilcox R G; Weaver W D; Gibler W B; Stebbins A L; Cianciolo C; Califf R M; Topol E J
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.
The American journal of cardiology 1999;84(11):1281-6.
1999: Califf R M; Holmes D R
Should the emergence of new agents change the management of patients with acute coronary syndromes without ST-segment elevation?
American heart journal 1999;138(6 Pt 2):S586-94.
1999: Whitlow P L; Dimas A P; Bashore T M; Califf R M; Bourassa M G; Chaitman B R; Rosen A D; Kip K E; Stadius M L; Alderman E L
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI).
Journal of the American College of Cardiology 1999;34(6):1750-9.
1999: Cohen M G; Granger C B; Ohman E M; Stebbins A L; Grinfeld L R; Cagide A M; Elizari M V; Betriu A; Kong D F; Topol E J; Califf R M
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1999;34(6):1729-37.
1999: Mahaffey K W; Puma J A; Barbagelata N A; DiCarli M F; Leesar M A; Browne K F; Eisenberg P R; Bolli R; Casas A C; Molina-Viamonte V; Orlandi C; Blevins R; Gibbons R J; Califf R M; Granger C B
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial.
Journal of the American College of Cardiology 1999;34(6):1711-20.
1999: Holmes D R; Berger P B; Hochman J S; Granger C B; Thompson T D; Califf R M; Vahanian A; Bates E R; Topol E J
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation.
Circulation 1999;100(20):2067-73.
1999: Kong D F; Topol E J; Bittl J A; White H D; Théroux P; Hasselblad V; Califf R M
Clinical outcomes of bivalirudin for ischemic heart disease.
Circulation 1999;100(20):2049-53.
1999: Boersma E; Akkerhuis K M; Théroux P; Califf R M; Topol E J; Simoons M L
Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
Circulation 1999;100(20):2045-8.
1999: Gilchrist I C; Gardner L H; Muhlestein J B; Arnold A M; Lincoff A M; Califf R M; Tcheng J E; Topol E J
Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience.
American heart journal 1999;138(5 Pt 1):976-82.
1999: McGuire D K; Califf R M
Diabetes and cardiovascular disease: current opinions and future directions.
American heart journal 1999;138(5 Pt 1):S327-9.
1999: Kong D F; Califf R M
Glycoprotein IIb/IIIa receptor antagonists in non-ST elevation acute coronary syndromes and percutaneous revascularisation: a review of trial reports.
Drugs 1999;58(4):609-20.
1999: Langer A; Fisher M; Califf R M; Goodman S; O'Connor C M; Harrington R A; Fuster V
Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
The Canadian journal of cardiology 1999;15(10):1095-102.
1999: Miller J M; Smalling R; Ohman E M; Bode C; Betriu A; Kleiman N S; Schildcrout J S; Bastos E; Topol E J; Califf R M
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries.
The American journal of cardiology 1999;84(7):779-84.
1999: Ryan T J; Antman E M; Brooks N H; Califf R M; Hillis L D; Hiratzka L F; Rapaport E; Riegel B; Russell R O; Smith E E; Weaver W D; Gibbons R J; Alpert J S; Eagle K A; Gardner T J; Garson A; Gregoratos G; Ryan T J; Smith S C
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Journal of the American College of Cardiology 1999;34(3):890-911.
1999: Mahaffey K W; Granger C B; Sloan M A; Green C L; Gore J M; Weaver W D; White H D; Simoons M L; Barbash G I; Topol E J; Califf R M
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.
American heart journal 1999;138(3 Pt 1):493-9.
1999: Van De Werf F; Adgey J; Ardissino D; Armstrong P W; Aylward P; Barbash G; Betriu A; Binbrek A S; Califf R; Diaz R; Fanebust R; Fox K; Granger C; Heikkilä J; Husted S; Jansky P; Langer A; Lupi E; Maseri A; Meyer J; Mlczoch J; Mocceti D; Myburgh D; Oto A; Paolasso E; Pehrsson K; Seabra-Gomes R; Soares-Piegas L; Sùgrue D; Tendera M; Topol E; Toutouzas P; Vahanian A; Verheugt F; Wallentin L; White H
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
Lancet 1999;354(9180):716-22.
1999: Ryan T J; Antman E M; Brooks N H; Califf R M; Hillis L D; Hiratzka L F; Rapaport E; Riegel B; Russell R O; Smith E E; Weaver W D; Gibbons R J; Alpert J S; Eagle K A; Gardner T J; Garson A; Gregoratos G; Smith S C
1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Circulation 1999;100(9):1016-30.
1999: Bart B A; Ertl G; Held P; Kuch J; Maggioni A P; McMurray J; Michelson E L; Rouleau J L; Warner Stevenson L; Swedberg K; Young J B; Yusuf S; Sellers M A; Granger C B; Califf R M; Pfeffer M A
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
European heart journal 1999;20(16):1182-90.
1999: Simoons M L; van den Brand M; Lincoff M; Harrington R; van der Wieken R; Vahanian A; Rutsch W; Kootstra J; Boersma E; Califf R M; Topol E
Minimal myocardial damage during coronary intervention is associated with impaired outcome.
European heart journal 1999;20(15):1112-9.
1999: Lincoff A M; Califf R M; Moliterno D J; Ellis S G; Ducas J; Kramer J H; Kleiman N S; Cohen E A; Booth J E; Sapp S K; Cabot C F; Topol E J
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
The New England journal of medicine 1999;341(5):319-27.
1999: Hochman J S; Tamis J E; Thompson T D; Weaver W D; White H D; Van de Werf F; Aylward P; Topol E J; Califf R M
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators.
The New England journal of medicine 1999;341(4):226-32.
1999: Batchelor W B; Peterson E D; Mark D B; Knight J D; Granger C B; Armstrong P W; Califf R M
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications.
Journal of the American College of Cardiology 1999;34(1):12-9.
1999: Berger P B; Ellis S G; Holmes D R; Granger C B; Criger D A; Betriu A; Topol E J; Califf R M
Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.
Circulation 1999;100(1):14-20.
1999: Califf R M
Glycoprotein IIb/IIIa blockade and thrombolytics: early lessons from the SPEED and GUSTO IV trials.
American heart journal 1999;138(1 Pt 2):S12-5.
1999: O'Connor C M; Gattis W A; Uretsky B F; Adams K F; McNulty S E; Grossman S H; McKenna W J; Zannad F; Swedberg K; Gheorghiade M; Califf R M
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
American heart journal 1999;138(1 Pt 1):78-86.
1999: Hasdai D; Holmes D R; Califf R M; Thompson T D; Hochman J S; Pfisterer M; Topol E J
Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
American heart journal 1999;138(1 Pt 1):21-31.
1999: Kong D F; Califf R M
Coronary interventions "to go": Is faster better?
The Journal of invasive cardiology 1999;11(6):401-2.
1999: McClure M W; Berkowitz S D; Sparapani R; Tuttle R; Kleiman N S; Berdan L G; Lincoff A M; Deckers J; Diaz R; Karsch K R; Gretler D; Kitt M; Simoons M; Topol E J; Califf R M; Harrington R A
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience.
Circulation 1999;99(22):2892-900.
1999: Mahaffey K W; Harrington R A; Simoons M L; Granger C B; Graffagnino C; Alberts M J; Laskowitz D T; Miller J M; Sloan M A; Berdan L G; MacAulay C M; Lincoff A M; Deckers J; Topol E J; Califf R M
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.
Circulation 1999;99(18):2371-7.
1999: Alexander J H; Granger C B; Sadowski Z; Aylward P E; White H D; Thompson T D; Califf R M; Topol E J
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.
American heart journal 1999;137(5):799-805.
1999: Califf R M; Stump D; Topol E J; Mark D B
Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy.
American heart journal 1999;137(5):S90-3.
1999: Califf R M
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics.
American heart journal 1999;137(5):S35-7.
1999: Alexander J H; Harrington R A; Tuttle R H; Berdan L G; Lincoff A M; Deckers J W; Simoons M L; Guerci A; Hochman J S; Wilcox R G; Kitt M M; Eisenberg P R; Califf R M; Topol E J; Karsh K; Ruzyllo W; Stepinska J; Widimsky P; Boland J B; Armstrong P W
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
The American journal of cardiology 1999;83(8):1147-51.
1999: Lincoff A M; Tcheng J E; Califf R M; Kereiakes D J; Kelly T A; Timmis G C; Kleiman N S; Booth J E; Balog C; Cabot C F; Anderson K M; Weisman H F; Topol E J
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.
Circulation 1999;99(15):1951-8.
1999: Adams K F; Sueta C A; Gheorghiade M; O'Connor C M; Schwartz T A; Koch G G; Uretsky B; Swedberg K; McKenna W; Soler-Soler J; Califf R M
Gender differences in survival in advanced heart failure. Insights from the FIRST study.
Circulation 1999;99(14):1816-21.
1999: Hasdai D; Lerman A; Rihal C S; Criger D A; Garratt K N; Betriu A; White H D; Topol E J; Granger C B; Ellis S G; Califf R M; Holmes D R
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction.
American heart journal 1999;137(4 Pt 1):612-20.
1999: Califf R M
What to do with acute atrial fibrillation?
American heart journal 1999;137(4 Pt 1):601-2.
1999: O'Connor C M; Gattis W A; Zannad F; McNulty S E; Gheorghiade M; Adams K F; Califf R M; McKenna W J; Soler-Soler J; Swedberg K
Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 1999;1(1):81-8.
1999: Narins C R; Miller D P; Califf R M; Topol E J
The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications.
Journal of the American College of Cardiology 1999;33(3):647-53.
1999: Puma J A; Sketch M H; Thompson T D; Simes R J; Morris D C; White H D; Topol E J; Califf R M
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy.
The American journal of cardiology 1999;83(4):482-7.
1999: Savonitto S; Ardissino D; Granger C B; Morando G; Prando M D; Mafrici A; Cavallini C; Melandri G; Thompson T D; Vahanian A; Ohman E M; Califf R M; Van de Werf F; Topol E J
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
JAMA : the journal of the American Medical Association 1999;281(8):707-13.
1999: Berger P B; Tuttle R H; Holmes D R; Topol E J; Aylward P E; Horgan J H; Califf R M
One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial.
Circulation 1999;99(7):873-8.
1999: Holmes D R; White H D; Pieper K S; Ellis S G; Califf R M; Topol E J
Effect of age on outcome with primary angioplasty versus thrombolysis.
Journal of the American College of Cardiology 1999;33(2):412-9.
1999: Detre K M; Guo P; Holubkov R; Califf R M; Sopko G; Bach R; Brooks M M; Bourassa M G; Shemin R J; Rosen A D; Krone R J; Frye R L; Feit F
Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI).
Circulation 1999;99(5):633-40.
1999: Thel M C; Califf R M; Tcheng J E; Sigmon K N; Lincoff A M; Topol E J; Ellis S G
Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators.
American heart journal 1999;137(2):264-73.
1999: Harrington R A; Califf R M; Holmes D R; Pieper K S; Lincoff A M; Berdan L G; Thompson T D; Topol E J
Is all unstable angina the same? insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). The CAVEAT-Investigators.
American heart journal 1999;137(2):227-33.
1999: Hasdai D; Holmes D R; Topol E J; Berger P B; Criger D A; Hochman J S; Bates E R; Vahanian A; Armstrong P W; Wilcox R; Ohman E M; Califf R M
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.
European heart journal 1999;20(2):128-35.
1999: Tardiff B E; Califf R M; Tcheng J E; Lincoff A M; Sigmon K N; Harrington R A; Mahaffey K W; Ohman E M; Teirstein P S; Blankenship J C; Kitt M M; Topol E J
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
Journal of the American College of Cardiology 1999;33(1):88-96.
1999: Tung C Y; Granger C B; Sloan M A; Topol E J; Knight J D; Weaver W D; Mahaffey K W; White H; Clapp-Channing N; Simoons M L; Gore J M; Califf R M; Mark D B
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
Circulation 1999;99(3):370-6.
1999: Reimer K A; Califf R M
Good news for experimental concept but bad news for clinically effective therapy.
Circulation 1999;99(2):198-200.
1999: Kleiman N S; Granger C B; White H D; Armstrong P; Ardissino D; de Werf F V; Zoldeyhi P; Thompson T D; Califf R M; Topol E J
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion.
American heart journal 1999;137(1):12-23.
1999: Barbagelata A; Di Carli M F; Sgarbossa E B; Califf R M; Clemmensen P; Criger D A; Gates K B; Gibbons R J; Casabe H; Granger C B; Wagner G S; Mahaffey K W
The use of tomographic myocardial perfusion scanning to evaluate an electrocardiographic salvage estimation method in patients with acute myocardial infarction: an AMISTAD substudy. Acute Myocardial Infarction Study Adenosine.
Journal of electrocardiology 1999;32 Suppl():111-3.
1998: Simons G R; Sgarbossa E; Wagner G; Califf R M; Topol E J; Natale A
Atrioventricular and intraventricular conduction disorders in acute myocardial infarction: a reappraisal in the thrombolytic era.
Pacing and clinical electrophysiology : PACE 1998;21(12):2651-63.
1998: Kong D F; Califf R M; Miller D P; Moliterno D J; White H D; Harrington R A; Tcheng J E; Lincoff A M; Hasselblad V; Topol E J
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease.
Circulation 1998;98(25):2829-35.
1998: Alexander K P; Peterson E D; Granger C B; Casas A C; Van de Werf F; Armstrong P W; Guerci A; Topol E J; Califf R M
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.
Journal of the American College of Cardiology 1998;32(7):2023-30.
1998: Califf R M
Ten years of benefit from a one-hour intervention.
Circulation 1998;98(24):2649-51.
1998: Newby K H; Thompson T; Stebbins A; Topol E J; Califf R M; Natale A
Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators.
Circulation 1998;98(23):2567-73.
1998: Ellis S G; Lincoff A M; Miller D; Tcheng J E; Kleiman N S; Kereiakes D; Califf R; Topol E J
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Blockade.
Journal of the American College of Cardiology 1998;32(6):1619-23.
1998: Bhatt D L; Lincoff A M; Kereiakes D J; Tcheng J E; Simoons M L; van der Wieken L R; Godfrey N; Califf R M; Topol E J
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention.
The American journal of cardiology 1998;82(9):1105-6, A6.
1998: Zabel K M; Granger C B; Becker R C; Bovill E G; Hirsh J; Aylward P E; Topol E J; Califf R M
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
American heart journal 1998;136(5):868-76.
1998: Armstrong P W; Fu Y; Chang W C; Topol E J; Granger C B; Betriu A; Van de Werf F; Lee K L; Califf R M
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.
Circulation 1998;98(18):1860-8.
1998: Newby L K; Christenson R H; Ohman E M; Armstrong P W; Thompson T D; Lee K L; Hamm C W; Katus H A; Cianciolo C; Granger C B; Topol E J; Califf R M
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators.
Circulation 1998;98(18):1853-9.
1998: Califf R M; Harrington R A
Improved outlook for patients with acute myocardial infarction: an interim progress report.
European heart journal 1998;19(10):1416-8.
1998: Califf R M
A perspective on the regulation of the evaluation of new antithrombotic drugs.
The American journal of cardiology 1998;82(8B):25P-35P.
1998: Califf R M
Role and significance of coagulation markers in understanding and treating acute coronary syndromes. Introduction.
American heart journal 1998;136(4 Pt 2 Su):S1-6.
1998: Anderson R D; Ohman E M; Holmes D R; Harrington R A; Barsness G W; Wildermann N M; Phillips H R; Topol E J; Califf R M
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions.
Journal of the American College of Cardiology 1998;32(4):936-41.
1998: Sloan M A; Sila C A; Mahaffey K W; Granger C B; Longstreth W T; Koudstaal P; White H D; Gore J M; Simoons M L; Weaver W D; Green C L; Topol E J; Califf R M
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Circulation 1998;98(14):1376-82.
1998: Lundergan C F; Reiner J S; McCarthy W F; Coyne K S; Califf R M; Ross A M
Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;32(3):641-7.
1998: Pfisterer M; Cox J L; Granger C B; Brener S J; Naylor C D; Califf R M; van de Werf F; Stebbins A L; Lee K L; Topol E J; Armstrong P W
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;32(3):634-40.
1998: Cohen M; Demers C; Gurfinkel E P; Turpie A G; Fromell G J; Goodman S; Langer A; Califf R M; Fox K A; Premmereur J; Bigonzi F
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
The American journal of cardiology 1998;82(5B):19L-24L.
1998: Califf R M
Robert McKinnon Califf, MD: a conversation with the editor. Interview by William Clifford Roberts.
The American journal of cardiology 1998;82(5):639-58.
1998: Krumholz H M; Phillips R S; Hamel M B; Teno J M; Bellamy P; Broste S K; Califf R M; Vidaillet H; Davis R B; Muhlbaier L H; Connors A F; Lynn J; Goldman L
Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Circulation 1998;98(7):648-55.
1998: Berkowitz S D; Sane D C; Sigmon K N; Shavender J H; Harrington R A; Tcheng J E; Topol E J; Califf R M
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group.
Journal of the American College of Cardiology 1998;32(2):311-9.
1998: Kong D F; Califf R M
Post-procedure heparin: boon or burden?
American heart journal 1998;136(2):183-5.
1998: Ghaffari S; Kereiakes D J; Lincoff A M; Kelly T A; Timmis G C; Kleiman N S; Ferguson J J; Miller D P; Califf R A; Topol E J
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade.
The American journal of cardiology 1998;82(1):7-12.
1998: Califf R M; Vidaillet H; Goldman L
Advanced congestive heart failure: What do patients want?
American heart journal 1998;135(6 Pt 2 Su):S320-6.
1998: Schulman K A; Mark D B; Califf R M
Outcomes and costs within a disease management program for advanced congestive heart failure.
American heart journal 1998;135(6 Pt 2 Su):S285-92.
1998: Mandak J S; Blankenship J C; Gardner L H; Berkowitz S D; Aguirre F V; Sigmon K N; Timmis G C; Gilchrist I C; McIvor M; Resar J; Weiner B H; George B S; Talley J D; Lincoff A M; Tcheng J E; Califf R M; Topol E J
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Journal of the American College of Cardiology 1998;31(7):1518-24.
1998: Metz B K; White H D; Granger C B; Simes R J; Armstrong P W; Hirsh J; Fuster V; MacAulay C M; Califf R M; Topol E J
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Journal of the American College of Cardiology 1998;31(7):1493-8.
1998: Kleiman N S; Lincoff A M; Kereiakes D J; Miller D P; Aguirre F V; Anderson K M; Weisman H F; Califf R M; Topol E J
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.
Circulation 1998;97(19):1912-20.
1998: Jaagosild P; Dawson N V; Thomas C; Wenger N S; Tsevat J; Knaus W A; Califf R M; Goldman L; Vidaillet H; Connors A F
Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. SUPPORT Investigators. The Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments.
Archives of internal medicine 1998;158(10):1081-9.
1998: Hochrein J; Sun F; Pieper K S; Lee K L; Gates K B; Armstrong P W; Weaver W D; Goodman S G; Topol E J; Califf R M; Granger C B; Wagner G S
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries.
The American journal of cardiology 1998;81(9):1078-84.
1998: Mark D B; Cowper P A; Berkowitz S D; Davidson-Ray L; DeLong E R; Turpie A G; Califf R M; Weatherley B; Cohen M
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction].
Circulation 1998;97(17):1702-7.
1998: Braunwald E; Maseri A; Armstrong P W; Califf R M; Gibler W B; Hamm C W; Simoons M L; Van de Werf F
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
European heart journal 1998;19 Suppl D():D22-30.
1998: Ross A M; Coyne K S; Moreyra E; Reiner J S; Greenhouse S W; Walker P L; Simoons M L; Draoui Y C; Califf R M; Topol E J; Van de Werf F; Lundergan C F
Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial.
Circulation 1998;97(16):1549-56.
1998: Califf R M; Kramer J M
What have we learned from the calcium channel blocker controversy?
Circulation 1998;97(16):1529-31.
1998: Califf R M; Granger C B
Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
Diabetes care 1998;21(4):655-7.
1998: Braunwald E; Maseri A; Armstrong P W; Califf R M; Gibler W B; Hamm C W; Simoons M L; Van de Werf F
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
American heart journal 1998;135(4):S56-66.
1998: Langer A; Krucoff M W; Klootwijk P; Simoons M L; Granger C B; Barr A; Califf R M; Armstrong P W
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
Journal of the American College of Cardiology 1998;31(4):783-9.
1998: Kereiakes D J; Lincoff A M; Miller D P; Tcheng J E; Cabot C F; Anderson K M; Weisman H F; Califf R M; Topol E J
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators.
Circulation 1998;97(9):857-64.
1998: Christenson R H; Duh S H; Newby L K; Ohman E M; Califf R M; Granger C B; Peck S; Pieper K S; Armstrong P W; Katus H A; Topol E J
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators.
Clinical chemistry 1998;44(3):494-501.
1998: Gebel J M; Sila C A; Sloan M A; Granger C B; Mahaffey K W; Weisenberger J; Green C L; White H D; Gore J M; Weaver W D; Califf R M; Topol E J
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Stroke; a journal of cerebral circulation 1998;29(3):563-9.
1998: Granger C B; Becker R; Tracy R P; Califf R M; Topol E J; Pieper K S; Ross A M; Roth S; Lambrew C; Bovill E G
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;31(3):497-505.
1998: Mahaffey K W; Granger C B; Sloan M A; Thompson T D; Gore J M; Weaver W D; White H D; Simoons M L; Barbash G I; Topol E J; Califf R M
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I.
Circulation 1998;97(8):757-64.
1998: Goodman S G; Langer A; Ross A M; Wildermann N M; Barbagelata A; Sgarbossa E B; Wagner G S; Granger C B; Califf R M; Topol E J; Simoons M L; Armstrong P W
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
Circulation 1998;97(5):444-50.
1998: Brieger D B; Mak K H; White H D; Kleiman N S; Miller D P; Vahanian A; Ross A M; Califf R M; Topol E J
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
The American journal of cardiology 1998;81(3):282-7.
1998: Omoigui N A; Silver M J; Rybicki L A; Rosenthal M; Berdan L G; Pieper K; King S V; Califf R M; Topol E J
Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators.
Journal of the American College of Cardiology 1998;31(2):265-72.
1998: Califf R M; Abdelmeguid A E; Kuntz R E; Popma J J; Davidson C J; Cohen E A; Kleiman N S; Mahaffey K W; Topol E J; Pepine C J; Lipicky R J; Granger C B; Harrington R A; Tardiff B E; Crenshaw B S; Bauman R P; Zuckerman B D; Chaitman B R; Bittl J A; Ohman E M
Myonecrosis after revascularization procedures.
Journal of the American College of Cardiology 1998;31(2):241-51.
1998: Hathaway W R; Peterson E D; Wagner G S; Granger C B; Zabel K M; Pieper K S; Clark K A; Woodlief L H; Califf R M
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
JAMA : the journal of the American Medical Association 1998;279(5):387-91.
1998: Blankenship J C; Hellkamp A S; Aguirre F V; Demko S L; Topol E J; Califf R M
Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial.
The American journal of cardiology 1998;81(1):36-40.
1998: Sgarbossa E B; Pinski S L; Topol E J; Califf R M; Barbagelata A; Goodman S G; Gates K B; Granger C B; Miller D P; Underwood D A; Wagner G S
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;31(1):105-10.
1998: Betriu A; Califf R M; Bosch X; Guerci A; Stebbins A L; Barbagelata N A; Aylward P E; Vahanian A; Van de Werf F; Topol E J
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1998;31(1):94-102.
1998: Khan M M; Ellis S G; Aguirre F V; Weisman H F; Wildermann N M; Califf R M; Topol E J; Kleiman N S
Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.
Journal of the American College of Cardiology 1998;31(1):31-6.
1997: Califf R M
The GUSTO trial and the open artery theory.
European heart journal 1997;18 Suppl F():F2-10.
1997: Califf R M; Karnash S L; Woodlief L H
Developing systems for cost-effective auditing of clinical trials.
Controlled clinical trials 1997;18(6):651-60; discussion 661-6.
1997: Mahaffey K W; Granger C B; Toth C A; White H D; Stebbins A L; Barbash G I; Vahanian A; Topol E J; Califf R M
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(7):1606-10.
1997: Califf R M; Mark D B
Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease.
American heart journal 1997;134(5 Pt 2):S88-96.
1997: Ohman E M; Califf R M; Topol E J
Trials in myocardial infarction.
Circulation 1997;96(10):3814-6.
1997: Shah A; Wagner G S; Califf R M; Boineau R E; Green C L; Wildermann N M; Trollinger K M; Pope J E; Krucoff M W
Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction.
Journal of the American College of Cardiology 1997;30(6):1478-83.
1997: Thel M C; Armstrong A L; McNulty S E; Califf R M; O'Connor C M
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff.
Lancet 1997;350(9087):1272-6.
1997: Barsness G W; Peterson E D; Ohman E M; Nelson C L; DeLong E R; Reves J G; Smith P K; Anderson R D; Jones R H; Mark D B; Califf R M
Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.
Circulation 1997;96(8):2551-6.
1997: Mak K H; Challapalli R; Eisenberg M J; Anderson K M; Califf R M; Topol E J
Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications.
The American journal of cardiology 1997;80(8):985-8.
1997: Bart B A; Shaw L K; McCants C B; Fortin D F; Lee K L; Califf R M; O'Connor C M
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy.
Journal of the American College of Cardiology 1997;30(4):1002-8.
1997: Selker H P; Griffith J L; Beshansky J R; Schmid C H; Califf R M; D'Agostino R B; Laks M M; Lee K L; Maynard C; Selvester R H; Wagner G S; Weaver W D
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument.
Annals of internal medicine 1997;127(7):538-56.
1997: Christenson R H; Ohman E M; Topol E J; Peck S; Newby L K; Duh S H; Kereiakes D J; Worley S J; Alosozana G L; Wall T C; Califf R M
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.
Circulation 1997;96(6):1776-82.
1997: Anderson R D; Ohman E M; Holmes D R; Col I; Stebbins A L; Bates E R; Stomel R J; Granger C B; Topol E J; Califf R M
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(3):708-15.
1997: Topol E J; Ferguson J J; Weisman H F; Tcheng J E; Ellis S G; Kleiman N S; Ivanhoe R J; Wang A L; Miller D P; Anderson K M; Califf R M
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
JAMA : the journal of the American Medical Association 1997;278(6):479-84.
1997: Cohen M; Demers C; Gurfinkel E P; Turpie A G; Fromell G J; Goodman S; Langer A; Califf R M; Fox K A; Premmereur J; Bigonzi F
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
The New England journal of medicine 1997;337(7):447-52.
1997: Crenshaw B S; Ward S R; Granger C B; Stebbins A L; Topol E J; Califf R M
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(2):406-13.
1997: Califf R M; Adams K F; McKenna W J; Gheorghiade M; Uretsky B F; McNulty S E; Darius H; Schulman K; Zannad F; Handberg-Thurmond E; Harrell F E; Wheeler W; Soler-Soler J; Swedberg K
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).
American heart journal 1997;134(1):44-54.
1997: Berger P B; Holmes D R; Stebbins A L; Bates E R; Califf R M; Topol E J
Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.
Circulation 1997;96(1):122-7.
1997: Migrino R Q; Young J B; Ellis S G; White H D; Lundergan C F; Miller D P; Granger C B; Ross A M; Califf R M; Topol E J
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators.
Circulation 1997;96(1):116-21.
1997: Mattimore T J; Wenger N S; Desbiens N A; Teno J M; Hamel M B; Liu H; Califf R; Connors A F; Lynn J; Oye R K
Surrogate and physician understanding of patients' preferences for living permanently in a nursing home.
Journal of the American Geriatrics Society 1997;45(7):818-24.
1997: Mak K H; Moliterno D J; Granger C B; Miller D P; White H D; Wilcox R G; Califf R M; Topol E J
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(1):171-9.
1997: Lincoff A M; Califf R M; Anderson K M; Weisman H F; Aguirre F V; Kleiman N S; Harrington R A; Topol E J
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.
Journal of the American College of Cardiology 1997;30(1):149-56.
1997: Moen E K; Asher C R; Miller D P; Weaver W D; White H D; Califf R M; Topol E J
Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1997;6(3):285-93.
1997: O'Connor C M; Hathaway W R; Bates E R; Leimberger J D; Sigmon K N; Kereiakes D J; George B S; Samaha J K; Abbottsmith C W; Candela R J; Topol E J; Califf R M
Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model.
American heart journal 1997;133(6):663-73.
1997: Califf R M; Woodlief L H; Harrell F E; Lee K L; White H D; Guerci A; Barbash G I; Simes R J; Weaver W D; Simoons M L; Topol E J
Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.
American heart journal 1997;133(6):630-9.
1997: Berkowitz S D; Granger C B; Pieper K S; Lee K L; Gore J M; Simoons M; Armstrong P W; Topol E J; Califf R M
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.
Circulation 1997;95(11):2508-16.
1997: Tsang T S; Califf R M; Stebbins A L; Lee K L; Cho S; Ross A M; Armstrong P W
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries.
The American journal of cardiology 1997;79(9):1232-5.
1997: Califf R M; Lee K L; Granger C B; Ohman E M
Predictors of outcome of reperfusion therapy.
European heart journal 1997;18(5):728-35.
1997: Jelesoff N E; Feinglos M; Granger C B; Califf R M
Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials.
Journal of cardiovascular risk 1997;4(2):100-11.
1997: Puma J A; Sketch M H; Tcheng J E; Gardner L H; Nelson C L; Phillips H R; Stack R S; Califf R M
The natural history of single-vessel chronic coronary occlusion: a 25-year experience.
American heart journal 1997;133(4):393-9.
1997: Eisenberg M J; Califf R M; Cohen E A; Adelman A G; Mark D B; Topol E J
Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators.
The American journal of cardiology 1997;79(7):867-72.
1997: Peterson E D; Shaw L J; Califf R M
Risk stratification after myocardial infarction.
Annals of internal medicine 1997;126(7):561-82.
1997: Barbagelata A; Califf R M; Sgarbossa E B; Goodman S G; Stebbins A L; Granger C B; Suarez L D; Borruel M; Gates K; Starr S; Wagner G S
Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.
Journal of the American College of Cardiology 1997;29(4):770-7.
1997: Califf R M; Woodlief L H
Pragmatic and mechanistic trials.
European heart journal 1997;18(3):367-70.
1997: Levine G N; Jacobs A K; Keeler G P; Whitlow P L; Berdan L G; Leya F; Topol E J; Califf R M
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial.
The American journal of cardiology 1997;79(6):748-55.
1997: Talley J D; Ohman E M; Mark D B; George B S; Leimberger J D; Berdan L G; Davidson-Ray L; Rawert M; Lam L C; Phillips H R; Califf R M
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump.
The American journal of cardiology 1997;79(5):590-4.
1997: Ward S R; Sutton J M; Pieper K S; Schwaiger M; Califf R M; Topol E J
Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction.
The American journal of cardiology 1997;79(5):539-44.
1997: Barbagelata N A; Granger C B; Oqueli E; Suárez L D; Borruel M; Topol E J; Califf R M
TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis.
American heart journal 1997;133(3):273-82.
1997: Topol E J; Califf R M; Van de Werf F; Simoons M; Hampton J; Lee K L; White H; Simes J; Armstrong P W
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.
Circulation 1997;95(4):1072-82.
1997: Ohman E M; Kleiman N S; Gacioch G; Worley S J; Navetta F I; Talley J D; Anderson H V; Ellis S G; Cohen M D; Spriggs D; Miller M; Kereiakes D; Yakubov S; Kitt M M; Sigmon K N; Califf R M; Krucoff M W; Topol E J
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.
Circulation 1997;95(4):846-54.
1997: Lincoff A M; Tcheng J E; Califf R M; Bass T; Popma J J; Teirstein P S; Kleiman N S; Hattel L J; Anderson H V; Ferguson J J; Cabot C F; Anderson K M; Berdan L G; Musco M H; Weisman H F; Topol E J
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.
The American journal of cardiology 1997;79(3):286-91.
1997: Peterson E D; Shaw L K; DeLong E R; Pryor D B; Califf R M; Mark D B
Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter?
The New England journal of medicine 1997;336(7):480-6.
1997: Tardiff B E; Califf R M; Morris D; Bates E; Woodlief L H; Lee K L; Green C; Rutsch W; Betriu A; Aylward P E; Topol E J
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;29(2):240-9.
1997: Califf R M; Mark D B
Our vision for the American Heart Journal.
American heart journal 1997;133(1):137-8.
1997: Holmes D R; Califf R M; Van de Werf F; Berger P B; Bates E R; Simoons M L; White H D; Thompson T D; Topol E J
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial.
Lancet 1997;349(9045):75-8.
1997: Woodfield S L; Lundergan C F; Reiner J S; Thompson M A; Rohrbeck S C; Deychak Y; Smith J O; Burton J R; McCarthy W F; Califf R M; White H D; Weaver W D; Topol E J; Ross A M
Gender and acute myocardial infarction: is there a different response to thrombolysis?
Journal of the American College of Cardiology 1997;29(1):35-42.
1997: FitzGerald J D; Wenger N S; Califf R M; Phillips R S; Desbiens N A; Liu H; Lynn J; Wu A W; Connors A F; Oye R K
Functional status among survivors of in-hospital cardiopulmonary resuscitation. SUPPORT Investigators Study to Understand Progress and Preferences for Outcomes and Risks of Treatment.
Archives of internal medicine 1997;157(1):72-6.
1997: Puopolo A L; Kennard M J; Mallatratt L; Follen M A; Desbiens N A; Conners A F; Califf R; Walzer J; Soukup J; Davis R B; Phillips R S
Preferences for cardiopulmonary resuscitation.
Image--the journal of nursing scholarship 1997;29(3):229-35.
1997: Eisenstein E L; Peterson E D; Jollis J G; Tardiff B E; Califf R M; Knight J D; Mark D B
Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application.
Proceedings : a conference of the American Medical Informatics Association / ... AMIA Annual Fall Symposium. AMIA Fall Symposium 1997;():273-7.
1996: Califf R M; Newby L K
How much do we gain by reducing time to reperfusion therapy?
The American journal of cardiology 1996;78(12A):8-15.
1996: Labinaz M; Sketch M H; Stebbins A L; DeFranco A C; Holmes D R; Kleiman N S; Betriu A; Rutsch W R; Vahanian A; Topol E J; Califf R M
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
The American journal of cardiology 1996;78(12):1338-44.
1996: Shaw L J; Peterson E D; Kesler K; Hasselblad V; Califf R M
A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging.
The American journal of cardiology 1996;78(12):1327-37.
1996: Aylward P E; Wilcox R G; Horgan J H; White H D; Granger C B; Califf R M; Topol E J
Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
Annals of internal medicine 1996;125(11):891-900.
1996: Woodfield S L; Lundergan C F; Reiner J S; Greenhouse S W; Thompson M A; Rohrbeck S C; Deychak Y; Simoons M L; Califf R M; Topol E J; Ross A M
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
Journal of the American College of Cardiology 1996;28(7):1661-9.
1996: Jollis J G; DeLong E R; Peterson E D; Muhlbaier L H; Fortin D F; Califf R M; Mark D B
Outcome of acute myocardial infarction according to the specialty of the admitting physician.
The New England journal of medicine 1996;335(25):1880-7.
1996: Brener S J; Leya F S; Apperson-Hansen C; Cowley M J; Califf R M; Topol E J
A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I Trial). Coronary Angioplasty Versus Excisional Atherectomy Trial-I.
The American journal of cardiology 1996;78(9):1039-41.
1996: Ryan T J; Anderson J L; Antman E M; Braniff B A; Brooks N H; Califf R M; Hillis L D; Hiratzka L F; Rapaport E; Riegel B J; Russell R O; Smith E E; Weaver W D
ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Circulation 1996;94(9):2341-50.
1996: Schulman S P; Goldschmidt-Clermont P J; Topol E J; Califf R M; Navetta F I; Willerson J T; Chandra N C; Guerci A D; Ferguson J J; Harrington R A; Lincoff A M; Yakubov S J; Bray P F; Bahr R D; Wolfe C L; Yock P G; Anderson H V; Nygaard T W; Mason S J; Effron M B; Fatterpacker A; Raskin S; Smith J; Brashears L; Gottdiener P; du Mee C; Kitt M M; Gerstenblith G
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
Circulation 1996;94(9):2083-9.
1996: Ryan T J; Anderson J L; Antman E M; Braniff B A; Brooks N H; Califf R M; Hillis L D; Hiratzka L F; Rapaport E; Riegel B J; Russell R O; Smith E E; Weaver W D
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
Journal of the American College of Cardiology 1996;28(5):1328-428.
1996: O'Brien J E; Peterson E D; Keeler G P; Berdan L G; Ohman E M; Faxon D P; Jacobs A K; Topol E J; Califf R M
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions.
Journal of the American College of Cardiology 1996;28(5):1111-8.
1996: Jelesoff N E; Feinglos M; Granger C B; Califf R M
Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials.
Coronary artery disease 1996;7(10):732-43.
1996: Veldkamp R F; Sawchak S; Pope J E; Califf R M; Krucoff M W
Performance of an automated real-time ST-segment analysis program to detect coronary occlusion and reperfusion.
Journal of electrocardiology 1996;29(4):257-63.
1996: White H D; Barbash G I; Califf R M; Simes R J; Granger C B; Weaver W D; Kleiman N S; Aylward P E; Gore J M; Vahanian A; Lee K L; Ross A M; Topol E J
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
Circulation 1996;94(8):1826-33.
1996: Ohman E M; Armstrong P W; Christenson R H; Granger C B; Katus H A; Hamm C W; O'Hanesian M A; Wagner G S; Kleiman N S; Harrell F E; Califf R M; Topol E J
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.
The New England journal of medicine 1996;335(18):1333-41.
1996: Lefkovits J; Blankenship J C; Anderson K M; Stoner G L; Talley J D; Worley S J; Weisman H F; Califf R M; Topol E J
Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic Complications.
Journal of the American College of Cardiology 1996;28(4):849-55.
1996: Pilote L; Miller D P; Califf R M; Rao J S; Weaver W D; Topol E J
Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction.
The New England journal of medicine 1996;335(16):1198-205.
1996: Califf R M
The rationale for thrombolytic therapy.
European heart journal 1996;17 Suppl E():2-8.
1996: Barefoot J C; Helms M J; Mark D B; Blumenthal J A; Califf R M; Haney T L; O'Connor C M; Siegler I C; Williams R B
Depression and long-term mortality risk in patients with coronary artery disease.
The American journal of cardiology 1996;78(6):613-7.
1996: Califf R M; White H D; Van de Werf F; Sadowski Z; Armstrong P W; Vahanian A; Simoons M L; Simes R J; Lee K L; Topol E J
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators.
Circulation 1996;94(6):1233-8.
1996: Eisenstein E L; Mark D B; Califf R M
Importance of cost and quality of life in decisions about routine angiography after acute myocardial infarction. The role of cost-effectiveness models.
Circulation 1996;94(5):869-71.
1996: Connors A F; Speroff T; Dawson N V; Thomas C; Harrell F E; Wagner D; Desbiens N; Goldman L; Wu A W; Califf R M; Fulkerson W J; Vidaillet H; Broste S; Bellamy P; Lynn J; Knaus W A
The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators.
JAMA : the journal of the American Medical Association 1996;276(11):889-97.
1996: Holmes D R; Garratt K N; Isner J M; Kearney M; Berdan L G; Schwartz R S; Califf R M; Topol E J
Effect of subintimal resection on initial outcome and restenosis for native coronary lesions and saphenous vein graft disease treated by directional coronary atherectomy. A report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial.
Journal of the American College of Cardiology 1996;28(3):645-51.
1996: Lesnefsky E J; Lundergan C F; Hodgson J M; Nair R; Reiner J S; Greenhouse S W; Califf R M; Ross A M
Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
Journal of the American College of Cardiology 1996;28(2):331-7.
1996: Peterson E D; Hathaway W R; Zabel K M; Pieper K S; Granger C B; Wagner G S; Topol E J; Bates E R; Simoons M L; Califf R M
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients.
Journal of the American College of Cardiology 1996;28(2):305-12.
1996: Mark D B; Talley J D; Topol E J; Bowman L; Lam L C; Anderson K M; Jollis J G; Cleman M W; Lee K L; Aversano T; Untereker W J; Davidson-Ray L; Califf R M
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators.
Circulation 1996;94(4):629-35.
1996: Midgette A S; Griffith J L; Califf R M; Laks M M; Dietz S B; Beshansky J R; Selker H P
Prediction of the infarct-related artery in acute myocardial infarction by a scoring system using summary ST-segment and T-wave changes.
The American journal of cardiology 1996;78(4):389-95.
1996: Hakim R B; Teno J M; Harrell F E; Knaus W A; Wenger N; Phillips R S; Layde P; Califf R; Connors A F; Lynn J
Factors associated with do-not-resuscitate orders: patients' preferences, prognoses, and physicians' judgments. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.
Annals of internal medicine 1996;125(4):284-93.
1996: Phillips R S; Hamel M B; Teno J M; Bellamy P; Broste S K; Califf R M; Vidaillet H; Davis R B; Muhlbaier L H; Connors A F
Race, resource use, and survival in seriously ill hospitalized adults. The SUPPORT Investigators.
Journal of general internal medicine 1996;11(7):387-96.
1996: Anderson J L; Karagounis L A; Califf R M
Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction.
The American journal of cardiology 1996;78(1):1-8.
1996: Rosenfeld K E; Wenger N S; Phillips R S; Connors A F; Dawson N V; Layde P; Califf R M; Liu H; Lynn J; Oye R K
Factors associated with change in resuscitation preference of seriously ill patients. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Archives of internal medicine 1996;156(14):1558-64.
1996: Califf R M; Tardiff B E; Pieper K S; Hillegass W B
Use of calcium channel antagonists in myocardial revascularization procedures.
The American journal of cardiology 1996;77(16):26D-31D.
1996: Newby L K; Rutsch W R; Califf R M; Simoons M L; Aylward P E; Armstrong P W; Woodlief L H; Lee K L; Topol E J; Van de Werf F
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.
Journal of the American College of Cardiology 1996;27(7):1646-55.
1996: Kennard M J; Speroff T; Puopolo A L; Follen M A; Mallatratt L; Phillips R; Desbiens N; Califf R M; Connors A F
Participation of nurses in decision making for seriously ill adults.
Clinical nursing research 1996;5(2):199-219.
1996: Lefkovits J; Ivanhoe R J; Califf R M; Bergelson B A; Anderson K M; Stoner G L; Weisman H F; Topol E J
Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators.
The American journal of cardiology 1996;77(12):1045-51.
1996: Jones R H; Kesler K; Phillips H R; Mark D B; Smith P K; Nelson C L; Newman M F; Reves J G; Anderson R W; Califf R M
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease.
The Journal of thoracic and cardiovascular surgery 1996;111(5):1013-25.
1996: Fetters J K; Peterson E D; Shaw L J; Newby L K; Califf R M
Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated?
American heart journal 1996;131(4):796-813.
1996: O'Connor C M; Meese R B; McNulty S; Lucas K D; Carney R J; LeBoeuf R M; Maddox W; Bethea C F; Shadoff N; Trahey T F; Heinsimer J A; Burks J M; O'Donnell G; Krucoff M W; Califf R M
A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators.
The American journal of cardiology 1996;77(10):791-7.
1996: Califf R M; Armstrong P W; Carver J R; D'Agostino R B; Strauss W E
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management.
Journal of the American College of Cardiology 1996;27(5):1007-19.
1996: Mahaffey K W; Granger C B; Collins R; O'Connor C M; Ohman E M; Bleich S D; Col J J; Califf R M
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
The American journal of cardiology 1996;77(8):551-6.
1996: Newby L K; Califf R M; Guerci A; Weaver W D; Col J; Horgan J H; Mark D B; Stebbins A; Van de Werf F; Gore J M; Topol E J
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial.
Journal of the American College of Cardiology 1996;27(3):625-32.
1996: Weaver W D; White H D; Wilcox R G; Aylward P E; Morris D; Guerci A; Ohman E M; Barbash G I; Betriu A; Sadowski Z; Topol E J; Califf R M
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
JAMA : the journal of the American Medical Association 1996;275(10):777-82.
1996: Granger C B; Hirsch J; Califf R M; Col J; White H D; Betriu A; Woodlief L H; Lee K L; Bovill E G; Simes R J; Topol E J
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.
Circulation 1996;93(5):870-8.
1996: Narins C R; Hillegass W B; Nelson C L; Tcheng J E; Harrington R A; Phillips H R; Stack R S; Califf R M
Relation between activated clotting time during angioplasty and abrupt closure.
Circulation 1996;93(4):667-71.
1996: Phillips R S; Wenger N S; Teno J; Oye R K; Youngner S; Califf R; Layde P; Desbiens N; Connors A F; Lynn J
Choices of seriously ill patients about cardiopulmonary resuscitation: correlates and outcomes. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
The American journal of medicine 1996;100(2):128-37.
1996: Jollis J G; Califf R M
A randomized study would answer the question.
The Annals of thoracic surgery 1996;61(2):513-4.
1996: Califf R M; Jollis J G; Peterson E D
Operator-specific outcomes. A call to professional responsibility.
Circulation 1996;93(3):403-6.
1996: Sgarbossa E B; Pinski S L; Barbagelata A; Underwood D A; Gates K B; Topol E J; Califf R M; Wagner G S
Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators.
The New England journal of medicine 1996;334(8):481-7.
1995: Karnash S L; Granger C B; White H D; Woodlief L H; Topol E J; Califf R M
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial.
Journal of the American College of Cardiology 1995;26(7):1651-6.
1995: Fortin D F; Califf R M; Pryor D B; Mark D B
The way of the future redux.
The American journal of cardiology 1995;76(16):1177-82.
1995: Califf R M; Lincoff A M; Tcheng J E; Topol E J
An overview of the results of the EPIC trial.
European heart journal 1995;16 Suppl L():43-9.
1995: Holmes D R; Simpson J B; Berdan L G; Gottlieb R S; Leya F; Keeler G P; Califf R M; Topol E J
Abrupt closure: the CAVEAT I experience. Coronary Angioplasty Versus Excisional Atherectomy Trial.
Journal of the American College of Cardiology 1995;26(6):1494-500.
1995: Barbagelata A; Granger C B; Topol E J; Worley S J; Kereiakes D J; George B S; Ohman E M; Leimberger J D; Mark D B; Califf R M
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group.
The American journal of cardiology 1995;76(14):1007-13.
1995: Omoigui N A; Califf R M; Pieper K; Keeler G; O'Hanesian M A; Berdan L G; Mark D B; Talley J D; Topol E J
Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I).
Journal of the American College of Cardiology 1995;26(4):922-30.
1995: Weitz J I; Califf R M; Ginsberg J S; Hirsh J; Théroux P
New antithrombotics.
Chest 1995;108(4 Suppl):471S-485S.
1995: Levine M N; Goldhaber S Z; Gore J M; Hirsh J; Califf R M
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.
Chest 1995;108(4 Suppl):291S-301S.
1995: Califf R M
Acute ischemic syndromes.
The Medical clinics of North America 1995;79(5):999-1024.
1995: Califf R M
Restenosis: the cost to society.
American heart journal 1995;130(3 Pt 2):680-4.
1995: Holmes D R; Bates E R; Kleiman N S; Sadowski Z; Horgan J H; Morris D C; Califf R M; Berger P B; Topol E J
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1995;26(3):668-74.
1995: Van de Werf F; Califf R M; Armstrong P W; Bates E R; Ross A M; Kleinman N S; Topol E J
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
European heart journal 1995;16(8):1024-6.
1995: Lefkovits J; Holmes D R; Califf R M; Safian R D; Pieper K; Keeler G; Topol E J
Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial.
Circulation 1995;92(4):734-40.
1995: Hlatky M A; Lam L C; Lee K L; Clapp-Channing N E; Williams R B; Pryor D B; Califf R M; Mark D B
Job strain and the prevalence and outcome of coronary artery disease.
Circulation 1995;92(3):327-33.
1995: Pilote L; Califf R M; Sapp S; Miller D P; Mark D B; Weaver W D; Gore J M; Armstrong P W; Ohman E M; Topol E J
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
The New England journal of medicine 1995;333(9):565-72.
1995: Califf R M
How should clinicians interpret clinical trials?
Cardiology clinics 1995;13(3):459-68.
1995: Puma J A; Sketch M H; Tcheng J E; Harrington R A; Phillips H R; Stack R S; Califf R M
Percutaneous revascularization of chronic coronary occlusions: an overview.
Journal of the American College of Cardiology 1995;26(1):1-11.
1995: Hamel M B; Goldman L; Teno J; Lynn J; Davis R B; Harrell F E; Connors A F; Califf R; Kussin P; Bellamy P
Identification of comatose patients at high risk for death or severe disability. SUPPORT Investigators. Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
JAMA : the journal of the American Medical Association 1995;273(23):1842-8.
1995: Holmes D R; Califf R M; Topol E J